BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ni J, Wu GD, Albenberg L, Tomov VT. Gut microbiota and IBD: causation or correlation? Nat Rev Gastroenterol Hepatol. 2017;14:573-584. [PMID: 28743984 DOI: 10.1038/nrgastro.2017.88] [Cited by in Crossref: 451] [Cited by in F6Publishing: 405] [Article Influence: 90.2] [Reference Citation Analysis]
Number Citing Articles
1 Pang J, Ding J, Zhang L, Zhang Y, Yang Y, Bai X, Liu X, Jin X, Guo H, Yang Y, Liu M. Effect of recombinant serine protease from adult stage of Trichinella spiralis on TNBS-induced experimental colitis in mice. Int Immunopharmacol 2020;86:106699. [PMID: 32570037 DOI: 10.1016/j.intimp.2020.106699] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
2 Kim WK, Han DH, Jang YJ, Park S, Jang SJ, Lee G, Han HS, Ko G. Alleviation of DSS-induced colitis via Lactobacillus acidophilus treatment in mice. Food Funct 2021;12:340-50. [PMID: 33325946 DOI: 10.1039/d0fo01724h] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Farias e Silva K, Nanini HF, Cascabulho CM, Rosas SLB, Santana PT, Carneiro AJV, Anaissie E, Nucci M, de Souza HSP. Serum 1,3-beta-D-glucan as a noninvasive test to predict histologic activity in patients with inflammatory bowel disease. World J Gastroenterol 2021; 27(9): 866-885 [PMID: 33727775 DOI: 10.3748/wjg.v27.i9.866] [Reference Citation Analysis]
4 Yang X, Lu D, Zhuo J, Lin Z, Yang M, Xu X. The Gut-liver Axis in Immune Remodeling: New insight into Liver Diseases. Int J Biol Sci 2020;16:2357-66. [PMID: 32760203 DOI: 10.7150/ijbs.46405] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
5 Licata A, Zerbo M, Como S, Cammilleri M, Soresi M, Montalto G, Giannitrapani L. The Role of Vitamin Deficiency in Liver Disease: To Supplement or Not Supplement? Nutrients 2021;13:4014. [PMID: 34836267 DOI: 10.3390/nu13114014] [Reference Citation Analysis]
6 Su L, Ma F, An Z, Ji X, Zhang P, Yue Q, Zhao C, Sun X, Li K, Li B, Liu X, Zhao L. The Metabolites of Lactobacillus fermentum F-B9-1 Relieved Dextran Sulfate Sodium-Induced Experimental Ulcerative Colitis in Mice. Front Microbiol 2022;13:865925. [PMID: 35572623 DOI: 10.3389/fmicb.2022.865925] [Reference Citation Analysis]
7 Neumann W, Sassone-Corsi M, Raffatellu M, Nolan EM. Esterase-Catalyzed Siderophore Hydrolysis Activates an Enterobactin-Ciprofloxacin Conjugate and Confers Targeted Antibacterial Activity. J Am Chem Soc 2018;140:5193-201. [PMID: 29578687 DOI: 10.1021/jacs.8b01042] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 14.3] [Reference Citation Analysis]
8 Kayama H, Takeda K. Manipulation of epithelial integrity and mucosal immunity by host and microbiota-derived metabolites. Eur J Immunol 2020;50:921-31. [PMID: 32511746 DOI: 10.1002/eji.201948478] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
9 Sun Z, Li J, Dai Y, Wang W, Shi R, Wang Z, Ding P, Lu Q, Jiang H, Pei W, Zhao X, Guo Y, Liu J, Tan X, Mao T. Indigo Naturalis Alleviates Dextran Sulfate Sodium-Induced Colitis in Rats via Altering Gut Microbiota. Front Microbiol 2020;11:731. [PMID: 32425906 DOI: 10.3389/fmicb.2020.00731] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
10 Li Y, Liu M, Zhou J, Hou B, Su X, Liu Z, Yuan J, Li M. Bacillus licheniformis Zhengchangsheng® attenuates DSS-induced colitis and modulates the gut microbiota in mice. Beneficial Microbes 2019;10:543-53. [DOI: 10.3920/bm2018.0122] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
11 Iannone LF, Gómez-Eguílaz M, Citaro R, Russo E. The potential role of interventions impacting on gut-microbiota in epilepsy. Expert Rev Clin Pharmacol 2020;13:423-35. [PMID: 32320306 DOI: 10.1080/17512433.2020.1759414] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
12 Iliopoulou L, Kollias G. Harnessing murine models of Crohn's disease ileitis to advance concepts of pathophysiology and treatment. Mucosal Immunol 2021. [PMID: 34316007 DOI: 10.1038/s41385-021-00433-3] [Reference Citation Analysis]
13 Spalinger MR, Schwarzfischer M, Niechcial A, Atrott K, Laimbacher A, Gottier C, Lang S, Scharl M. Loss of PTPN22 promotes intestinal inflammation by compromising granulocyte-mediated anti-bacterial defense. J Crohns Colitis 2021:jjab098. [PMID: 34089589 DOI: 10.1093/ecco-jcc/jjab098] [Reference Citation Analysis]
14 Harriman R, Lewis JS. Bioderived materials that disarm the gut mucosal immune system: Potential lessons from commensal microbiota. Acta Biomater 2021;133:187-207. [PMID: 34098091 DOI: 10.1016/j.actbio.2021.05.045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Hu B, Yu S, Shi C, Gu J, Shao Y, Chen Q, Li Y, Mezzenga R. Amyloid-Polyphenol Hybrid Nanofilaments Mitigate Colitis and Regulate Gut Microbial Dysbiosis. ACS Nano 2020;14:2760-76. [PMID: 31961657 DOI: 10.1021/acsnano.9b09125] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 21.5] [Reference Citation Analysis]
16 Diaz OE, Morales RA, Das S, Villablanca EJ. Experimental Models of Intestinal Inflammation: Lessons from Mouse and Zebrafish. In: Hedin C, Rioux JD, D'amato M, editors. Molecular Genetics of Inflammatory Bowel Disease. Cham: Springer International Publishing; 2019. pp. 47-76. [DOI: 10.1007/978-3-030-28703-0_3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Li K, Feng C, Chen H, Feng Y, Li J. Trends in Worldwide Research in Inflammatory Bowel Disease Over the Period 2012–2021: A Bibliometric Study. Front Med 2022;9:880553. [DOI: 10.3389/fmed.2022.880553] [Reference Citation Analysis]
18 Jarmakiewicz-Czaja S, Sokal A, Filip R. What was First, Obesity or Inflammatory Bowel Disease? What Does the Gut Microbiota Have to Do with It? Nutrients 2020;12:E3073. [PMID: 33050109 DOI: 10.3390/nu12103073] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
19 Wang H, Wei C, Min L, Zhu L. Good or bad: gut bacteria in human health and diseases. Biotechnology & Biotechnological Equipment 2018;32:1075-80. [DOI: 10.1080/13102818.2018.1481350] [Cited by in Crossref: 24] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
20 Starr AE, Deeke SA, Li L, Zhang X, Daoud R, Ryan J, Ning Z, Cheng K, Nguyen LVH, Abou-samra E, Lavallée-adam M, Figeys D. Proteomic and Metaproteomic Approaches to Understand Host–Microbe Interactions. Anal Chem 2017;90:86-109. [DOI: 10.1021/acs.analchem.7b04340] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
21 Guo F, Cai D, Li Y, Gu H, Qu H, Zong Q, Bao W, Chen A, Liu HY. How Early-Life Gut Microbiota Alteration Sets Trajectories for Health and Inflammatory Bowel Disease? Front Nutr 2021;8:690073. [PMID: 34422881 DOI: 10.3389/fnut.2021.690073] [Reference Citation Analysis]
22 Rodríguez C, Romero E, Garrido-Sanchez L, Alcaín-Martínez G, Andrade RJ, Taminiau B, Daube G, García-Fuentes E. MICROBIOTA INSIGHTS IN CLOSTRIDIUM DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE. Gut Microbes 2020;12:1725220. [PMID: 32129694 DOI: 10.1080/19490976.2020.1725220] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
23 Friedrich V, Forné I, Matzek D, Ring D, Popper B, Jochum L, Spriewald S, Straub T, Imhof A, Krug A, Stecher B, Brocker T. Helicobacter hepaticus is required for immune targeting of bacterial heat shock protein 60 and fatal colitis in mice. Gut Microbes 2021;13:1-20. [PMID: 33550886 DOI: 10.1080/19490976.2021.1882928] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Sireswar S, Dey G. Matrix-wise evaluation of in vivo and in vitro efficiencies of L. rhamnosus GG-fortified beverages. Food Res Int 2019;119:908-19. [PMID: 30884731 DOI: 10.1016/j.foodres.2018.10.077] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
25 Hvas CL, Bendix M, Dige A, Dahlerup JF, Agnholt J. Current, experimental, and future treatments in inflammatory bowel disease: a clinical review. Immunopharmacol Immunotoxicol 2018;40:446-60. [PMID: 29745777 DOI: 10.1080/08923973.2018.1469144] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
26 Zhu X, Xiang S, Feng X, Wang H, Tian S, Xu Y, Shi L, Yang L, Li M, Shen Y, Chen J, Chen Y, Han J. Impact of Cyanocobalamin and Methylcobalamin on Inflammatory Bowel Disease and the Intestinal Microbiota Composition. J Agric Food Chem 2019;67:916-26. [DOI: 10.1021/acs.jafc.8b05730] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
27 Nielsen HL, Dalager-Pedersen M, Nielsen H. Risk of inflammatory bowel disease after Campylobacter jejuni and Campylobacter concisus infection: a population-based cohort study. Scand J Gastroenterol 2019;54:265-72. [PMID: 30905214 DOI: 10.1080/00365521.2019.1578406] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
28 Alam A, Neish A. Role of gut microbiota in intestinal wound healing and barrier function. Tissue Barriers 2018;6:1539595. [PMID: 30404570 DOI: 10.1080/21688370.2018.1539595] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
29 Walter J, Armet AM, Finlay BB, Shanahan F. Establishing or Exaggerating Causality for the Gut Microbiome: Lessons from Human Microbiota-Associated Rodents.Cell. 2020;180:221-232. [PMID: 31978342 DOI: 10.1016/j.cell.2019.12.025] [Cited by in Crossref: 121] [Cited by in F6Publishing: 109] [Article Influence: 60.5] [Reference Citation Analysis]
30 Xuan-Qing CHEN, Xiang-Yu LV, Shi-Jia LIU. Baitouweng decoction alleviates dextran sulfate sodium-induced ulcerative colitis by regulating intestinal microbiota and the IL-6/STAT3 signaling pathway. J Ethnopharmacol 2021;265:113357. [PMID: 32891820 DOI: 10.1016/j.jep.2020.113357] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
31 Wang J, Lin S, Brown JM, van Wagoner D, Fiocchi C, Rieder F. Novel mechanisms and clinical trial endpoints in intestinal fibrosis. Immunol Rev 2021;302:211-27. [PMID: 33993489 DOI: 10.1111/imr.12974] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
32 Li W, Sun Y, Dai L, Chen H, Yi B, Niu J, Wang L, Zhang F, Luo J, Wang K, Guo R, Li L, Zou Q, Ma ZS, Miao Y. Ecological and network analyses identify four microbial species with potential significance for the diagnosis/treatment of ulcerative colitis (UC). BMC Microbiol 2021;21:138. [PMID: 33947329 DOI: 10.1186/s12866-021-02201-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Long J, Liu XK, Kang ZP, Wang MX, Zhao HM, Huang JQ, Xiao QP, Liu DY, Zhong YB. Ginsenoside Rg1 ameliorated experimental colitis by regulating the balance of M1/M2 macrophage polarization and the homeostasis of intestinal flora. Eur J Pharmacol 2022;917:174742. [PMID: 34999087 DOI: 10.1016/j.ejphar.2022.174742] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
34 Kang Y, Yang G, Zhang S, Ross CF, Zhu MJ. Goji Berry Modulates Gut Microbiota and Alleviates Colitis in IL-10-Deficient Mice. Mol Nutr Food Res. 2018;62:e1800535. [PMID: 30243032 DOI: 10.1002/mnfr.201800535] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 6.5] [Reference Citation Analysis]
35 Liu J, Wang M, Chen W, Ma J, Peng Y, Zhang M, Wang C, Yan G, Lu G. Altered Gut Microbiota Taxonomic Compositions of Patients With Sepsis in a Pediatric Intensive Care Unit. Front Pediatr 2021;9:645060. [PMID: 33898360 DOI: 10.3389/fped.2021.645060] [Reference Citation Analysis]
36 Caër C, Wick MJ. Human Intestinal Mononuclear Phagocytes in Health and Inflammatory Bowel Disease. Front Immunol 2020;11:410. [PMID: 32256490 DOI: 10.3389/fimmu.2020.00410] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
37 Tang B, Zhu J, Fang S, Wang Y, Vinothkumar R, Li M, Weng Q, Zheng L, Yang Y, Qiu R, Xu M, Zhao Z, Ji J. Pharmacological inhibition of MELK restricts ferroptosis and the inflammatory response in colitis and colitis-propelled carcinogenesis. Free Radic Biol Med 2021;172:312-29. [PMID: 34144192 DOI: 10.1016/j.freeradbiomed.2021.06.012] [Reference Citation Analysis]
38 Tian S, Li J, Li R, Liu Z, Dong W. Decreased Serum Bilirubin Levels and Increased Uric Acid Levels are Associated with Ulcerative Colitis. Med Sci Monit 2018;24:6298-304. [PMID: 30196310 DOI: 10.12659/MSM.909692] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
39 Yang J, Chun J. Taxonomic composition and variation in the gut microbiota of laboratory mice. Mamm Genome 2021;32:297-310. [PMID: 33893864 DOI: 10.1007/s00335-021-09871-7] [Reference Citation Analysis]
40 Li X, Zhang ZH, Zabed HM, Yun J, Zhang G, Qi X. An Insight into the Roles of Dietary Tryptophan and Its Metabolites in Intestinal Inflammation and Inflammatory Bowel Disease. Mol Nutr Food Res 2021;65:e2000461. [PMID: 33216452 DOI: 10.1002/mnfr.202000461] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
41 Newman KM, Vaughn BP. Efficacy of intestinal microbiota transplantation in ulcerative colitis: a review of current literature and knowledge. Minerva Gastroenterol Dietol 2019;65. [DOI: 10.23736/s1121-421x.19.02610-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
42 Fujita Y, Khateb A, Li Y, Tinoco R, Zhang T, Bar-Yoseph H, Tam MA, Chowers Y, Sabo E, Gerassy-Vainberg S, Starosvetsky E, James B, Brown K, Shen-Orr SS, Bradley LM, Tessier PA, Ronai ZA. Regulation of S100A8 Stability by RNF5 in Intestinal Epithelial Cells Determines Intestinal Inflammation and Severity of Colitis. Cell Rep 2018;24:3296-3311.e6. [PMID: 30232010 DOI: 10.1016/j.celrep.2018.08.057] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
43 Leonardi I, Li X, Iliev ID. Macrophage interactions with fungi and bacteria in inflammatory bowel disease. Curr Opin Gastroenterol 2018;34:392-7. [PMID: 30239343 DOI: 10.1097/MOG.0000000000000479] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
44 Bergsten E, Mestivier D, Sobhani I. The Limits and Avoidance of Biases in Metagenomic Analyses of Human Fecal Microbiota. Microorganisms 2020;8:E1954. [PMID: 33317070 DOI: 10.3390/microorganisms8121954] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
45 Liu YJ, Tang B, Wang FC, Tang L, Lei YY, Luo Y, Huang SJ, Yang M, Wu LY, Wang W, Liu S, Yang SM, Zhao XY. Parthenolide ameliorates colon inflammation through regulating Treg/Th17 balance in a gut microbiota-dependent manner. Theranostics 2020;10:5225-41. [PMID: 32373209 DOI: 10.7150/thno.43716] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 21.5] [Reference Citation Analysis]
46 Little R, Wine E, Kamath BM, Griffiths AM, Ricciuto A. Gut microbiome in primary sclerosing cholangitis: A review. World J Gastroenterol 2020; 26(21): 2768-2780 [PMID: 32550753 DOI: 10.3748/wjg.v26.i21.2768] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 17] [Article Influence: 12.5] [Reference Citation Analysis]
47 Spalinger MR, Schmidt TS, Schwarzfischer M, Hering L, Atrott K, Lang S, Gottier C, Geirnaert A, Lacroix C, Dai X, Rawlings DJ, Chan AC, von Mering C, Rogler G, Scharl M. Protein tyrosine phosphatase non-receptor type 22 modulates colitis in a microbiota-dependent manner. J Clin Invest 2019;129:2527-41. [PMID: 31107248 DOI: 10.1172/JCI123263] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
48 Dawwas GK, Brensinger CM, Vajravelu RK, Wu Q, Kelly CR, Laine L, Wu GD, Lewis JD. Long-term Outcomes Following Multiply Recurrent Clostridioides difficile Infection and Fecal Microbiota Transplantation. Clin Gastroenterol Hepatol 2020:S1542-3565(20)31642-6. [PMID: 33307184 DOI: 10.1016/j.cgh.2020.12.004] [Reference Citation Analysis]
49 Mohebali N, Ekat K, Kreikemeyer B, Breitrück A. Barrier Protection and Recovery Effects of Gut Commensal Bacteria on Differentiated Intestinal Epithelial Cells In Vitro. Nutrients 2020;12:E2251. [PMID: 32731411 DOI: 10.3390/nu12082251] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
50 Li X, Hu D, Tian Y, Song Y, Hou Y, Sun L, Zhang Y, Man C, Zhang W, Jiang Y. Protective effects of a novel Lactobacillus rhamnosus strain with probiotic characteristics against lipopolysaccharide-induced intestinal inflammation in vitro and in vivo. Food Funct 2020;11:5799-814. [PMID: 32568317 DOI: 10.1039/d0fo00308e] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
51 Navarro MN, Gómez de Las Heras MM, Mittelbrunn M. Nicotinamide adenine dinucleotide metabolism in the immune response, autoimmunity and inflammageing. Br J Pharmacol 2021. [PMID: 33817782 DOI: 10.1111/bph.15477] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Duan Y, Young R, Schnabl B. Bacteriophages and their potential for treatment of gastrointestinal diseases. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34782783 DOI: 10.1038/s41575-021-00536-z] [Reference Citation Analysis]
53 Gu Z, Duan M, Sun Y, Leng T, Xu T, Gu Y, Gu Z, Lin Z, Yang L, Ji M. Effects of Vitamin D3 on Intestinal Flora in a Mouse Model of Inflammatory Bowel Disease Treated with Rifaximin. Med Sci Monit 2020;26:e925068. [PMID: 33177483 DOI: 10.12659/MSM.925068] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
54 Lucafò M, Franzin M, Lagatolla C, Franca R, Bramuzzo M, Stocco G, Decorti G. Emerging Insights on the Interaction Between Anticancer and Immunosuppressant Drugs and Intestinal Microbiota in Pediatric Patients. Clin Transl Sci 2020;13:238-59. [PMID: 31675176 DOI: 10.1111/cts.12722] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
55 Jiang P, Wu S, Luo Q, Zhao XM, Chen WH. Metagenomic Analysis of Common Intestinal Diseases Reveals Relationships among Microbial Signatures and Powers Multidisease Diagnostic Models. mSystems 2021;6:e00112-21. [PMID: 33947803 DOI: 10.1128/mSystems.00112-21] [Reference Citation Analysis]
56 Lohning A, Kidachi Y, Kamiie K, Sasaki K, Ryoyama K, Yamaguchi H. 6-(methylsulfinyl)hexyl isothiocyanate (6-MITC) from Wasabia japonica alleviates inflammatory bowel disease (IBD) by potential inhibition of glycogen synthase kinase 3 beta (GSK-3β). Eur J Med Chem 2021;216:113250. [PMID: 33691258 DOI: 10.1016/j.ejmech.2021.113250] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Geng Y, Yue Y, Guan Q, Ren Y, Guo L, Fan Y, Lu ZM, Shi JS, Xu ZH. Cereal Vinegar Sediment Alleviates Spontaneous Ulcerative Colitis in Il-10 Deficient Mice. Mol Nutr Food Res 2021;:e2001227. [PMID: 34699119 DOI: 10.1002/mnfr.202001227] [Reference Citation Analysis]
58 Durant L, Stentz R, Noble A, Brooks J, Gicheva N, Reddi D, O'Connor MJ, Hoyles L, McCartney AL, Man R, Pring ET, Dilke S, Hendy P, Segal JP, Lim DNF, Misra R, Hart AL, Arebi N, Carding SR, Knight SC. Bacteroides thetaiotaomicron-derived outer membrane vesicles promote regulatory dendritic cell responses in health but not in inflammatory bowel disease. Microbiome 2020;8:88. [PMID: 32513301 DOI: 10.1186/s40168-020-00868-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
59 Kai L, Zong X, Jiang Q, Lu Z, Wang F, Wang Y, Wang T, Jin M. Protective effects of polysaccharides from Atractylodes macrocephalae Koidz. against dextran sulfate sodium induced intestinal mucosal injury on mice. Int J Biol Macromol 2022;195:142-51. [PMID: 34896465 DOI: 10.1016/j.ijbiomac.2021.12.042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Xie Z, Wang Y, Yang G, Han J, Zhu L, Li L, Zhang S. The role of the Hippo pathway in the pathogenesis of inflammatory bowel disease. Cell Death Dis 2021;12:79. [PMID: 33436549 DOI: 10.1038/s41419-021-03395-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
61 Musleh-vega S, Ojeda J, Vidal PM. Gut Microbiota–Brain Axis as a Potential Modulator of Psychological Stress after Spinal Cord Injury. Biomedicines 2022;10:847. [DOI: 10.3390/biomedicines10040847] [Reference Citation Analysis]
62 Korf JM, Ganesh BP, Mccullough LD. Gut dysbiosis and age-related neurological diseases in females. Neurobiology of Disease 2022;168:105695. [DOI: 10.1016/j.nbd.2022.105695] [Reference Citation Analysis]
63 Peng Y, Yan Y, Wan P, Dong W, Huang K, Ran L, Mi J, Lu L, Zeng X, Cao Y. Effects of long-term intake of anthocyanins from Lycium ruthenicum Murray on the organism health and gut microbiota in vivo. Food Res Int 2020;130:108952. [PMID: 32156393 DOI: 10.1016/j.foodres.2019.108952] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
64 Mishra J, Stubbs M, Kuang L, Vara N, Kumar P, Kumar N, Subramanian VS. Inflammatory Bowel Disease Therapeutics: A Focus on Probiotic Engineering. Mediators of Inflammation 2022;2022:1-15. [DOI: 10.1155/2022/9621668] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
65 Phan K, Tatian A, Woods J, Cains G, Frew JW. Prevalence of inflammatory bowel disease (IBD) in hidradenitis suppurativa (HS): systematic review and adjusted meta‐analysis. Int J Dermatol 2019;59:221-8. [DOI: 10.1111/ijd.14697] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
66 Aldars-García L, Marin AC, Chaparro M, Gisbert JP. The Interplay between Immune System and Microbiota in Inflammatory Bowel Disease: A Narrative Review. Int J Mol Sci 2021;22:3076. [PMID: 33802883 DOI: 10.3390/ijms22063076] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Agus A, Clément K, Sokol H. Gut microbiota-derived metabolites as central regulators in metabolic disorders. Gut 2021;70:1174-82. [PMID: 33272977 DOI: 10.1136/gutjnl-2020-323071] [Cited by in Crossref: 104] [Cited by in F6Publishing: 79] [Article Influence: 104.0] [Reference Citation Analysis]
68 Cai S, Fan Y, Zhang B, Lin J, Yang X, Liu Y, Liu J, Ren J, Xu H. Appendectomy Is Associated With Alteration of Human Gut Bacterial and Fungal Communities. Front Microbiol 2021;12:724980. [PMID: 34603252 DOI: 10.3389/fmicb.2021.724980] [Reference Citation Analysis]
69 Aldars-García L, Chaparro M, Gisbert JP. Systematic Review: The Gut Microbiome and Its Potential Clinical Application in Inflammatory Bowel Disease. Microorganisms 2021;9:977. [PMID: 33946482 DOI: 10.3390/microorganisms9050977] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
70 Dent E, Davinson N, Wilkie S. The impact of gastrointestinal conditions on psychosocial factors associated with the biopsychosocial model of health: A scoping review. Appl Psychol Health Well Being 2021. [PMID: 34866337 DOI: 10.1111/aphw.12323] [Reference Citation Analysis]
71 De Zuani M, Dal Secco C, Frossi B. Mast cells at the crossroads of microbiota and IBD. Eur J Immunol 2018;48:1929-37. [PMID: 30411335 DOI: 10.1002/eji.201847504] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
72 Ishida T, Matsui H, Matsuda Y, Hosomi R, Shimono T, Kanda S, Nishiyama T, Fukunaga K, Yoshida M. Oyster (Crassostrea gigas) Extract Attenuates Dextran Sulfate Sodium-Induced Acute Experimental Colitis by Improving Gut Microbiota and Short-Chain Fatty Acids Compositions in Mice. Foods 2022;11:373. [DOI: 10.3390/foods11030373] [Reference Citation Analysis]
73 Edogawa S, Peters SA, Jenkins GD, Gurunathan SV, Sundt WJ, Johnson S, Lennon RJ, Dyer RB, Camilleri M, Kashyap PC, Farrugia G, Chen J, Singh RJ, Grover M. Sex differences in NSAID-induced perturbation of human intestinal barrier function and microbiota. FASEB J 2018;:fj201800560R. [PMID: 29897814 DOI: 10.1096/fj.201800560R] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
74 Chua LL, Rajasuriar R, Lim YAL, Woo YL, Loke P, Ariffin H. Temporal changes in gut microbiota profile in children with acute lymphoblastic leukemia prior to commencement-, during-, and post-cessation of chemotherapy. BMC Cancer 2020;20:151. [PMID: 32093640 DOI: 10.1186/s12885-020-6654-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
75 Siraj YA, Biadgelign MG, Yassin MO, Chekol YZ. Mucosa-associated cultivable aerobic gut bacterial microbiota among colorectal cancer patients attending at the referral hospitals of Amhara Regional State, Ethiopia. Gut Pathog 2021;13:19. [PMID: 33752753 DOI: 10.1186/s13099-021-00415-7] [Reference Citation Analysis]
76 Xu C, Lee SK, Zhang D, Frenette PS. The Gut Microbiome Regulates Psychological-Stress-Induced Inflammation. Immunity 2020;53:417-428.e4. [PMID: 32735844 DOI: 10.1016/j.immuni.2020.06.025] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
77 Čaja F, Stakheev D, Chernyavskiy O, Křížan J, Dvořák J, Rossmann P, Štěpánková R, Makovický P, Makovický P, Kozáková H, Vannucci L. Immune activation by microbiome shapes the colon mucosa: Comparison between healthy rat mucosa under conventional and germ-free conditions. J Immunotoxicol 2021;18:37-49. [PMID: 33749490 DOI: 10.1080/1547691X.2021.1887412] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Mendes V, Galvão I, Vieira AT. Mechanisms by Which the Gut Microbiota Influences Cytokine Production and Modulates Host Inflammatory Responses. J Interferon Cytokine Res 2019;39:393-409. [PMID: 31013453 DOI: 10.1089/jir.2019.0011] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
79 Zhou X, Xiang X, Zhou Y, Zhou T, Deng S, Zheng B, Zheng P. Protective effects of Antarctic krill oil in dextran sulfate sodium-induced ulcerative colitis mice. Journal of Functional Foods 2021;79:104394. [DOI: 10.1016/j.jff.2021.104394] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 9.0] [Reference Citation Analysis]
80 Marlicz W, Skonieczna-Żydecka K, Dabos KJ, Łoniewski I, Koulaouzidis A. Emerging concepts in non-invasive monitoring of Crohn's disease. Therap Adv Gastroenterol 2018;11:1756284818769076. [PMID: 29707039 DOI: 10.1177/1756284818769076] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
81 Thuy-Boun PS, Wang AY, Crissien-Martinez A, Xu JH, Chatterjee S, Stupp GS, Su AI, Coyle WJ, Wolan DW. Quantitative metaproteomics and activity-based protein profiling of patient fecal microbiome identifies host and microbial serine-type endopeptidase activity associated with ulcerative colitis. Mol Cell Proteomics 2022;:100197. [PMID: 35033677 DOI: 10.1016/j.mcpro.2022.100197] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Neumann C, Blume J, Roy U, Teh PP, Vasanthakumar A, Beller A, Liao Y, Heinrich F, Arenzana TL, Hackney JA, Eidenschenk C, Gálvez EJC, Stehle C, Heinz GA, Maschmeyer P, Sidwell T, Hu Y, Amsen D, Romagnani C, Chang H, Kruglov A, Mashreghi M, Shi W, Strowig T, Rutz S, Kallies A, Scheffold A. c-Maf-dependent Treg cell control of intestinal TH17 cells and IgA establishes host–microbiota homeostasis. Nat Immunol 2019;20:471-81. [DOI: 10.1038/s41590-019-0316-2] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 20.0] [Reference Citation Analysis]
83 Kitae H, Takagi T, Naito Y, Inoue R, Azuma Y, Torii T, Mizushima K, Doi T, Inoue K, Dohi O, Yoshida N, Kamada K, Uchiyama K, Ishikawa T, Konishi H, Itoh Y. Gut Microbiota Associated with Clinical Relapse in Patients with Quiescent Ulcerative Colitis. Microorganisms 2022;10:1044. [DOI: 10.3390/microorganisms10051044] [Reference Citation Analysis]
84 Ferrer-Picón E, Dotti I, Corraliza AM, Mayorgas A, Esteller M, Perales JC, Ricart E, Masamunt MC, Carrasco A, Tristán E, Esteve M, Salas A. Intestinal Inflammation Modulates the Epithelial Response to Butyrate in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis 2020;26:43-55. [PMID: 31211831 DOI: 10.1093/ibd/izz119] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 14.0] [Reference Citation Analysis]
85 Gracey E, Vereecke L, McGovern D, Fröhling M, Schett G, Danese S, De Vos M, Van den Bosch F, Elewaut D. Revisiting the gut-joint axis: links between gut inflammation and spondyloarthritis. Nat Rev Rheumatol 2020;16:415-33. [PMID: 32661321 DOI: 10.1038/s41584-020-0454-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 12.0] [Reference Citation Analysis]
86 Bistoletti M, Micheloni G, Baranzini N, Bosi A, Conti A, Filpa V, Pirrone C, Millefanti G, Moro E, Grimaldi A, Valli R, Baj A, Crema F, Giaroni C, Porta G. Homeoprotein OTX1 and OTX2 involvement in rat myenteric neuron adaptation after DNBS-induced colitis. PeerJ 2020;8:e8442. [PMID: 32095330 DOI: 10.7717/peerj.8442] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
87 Guo X, Huang C, Xu J, Xu H, Liu L, Zhao H, Wang J, Huang W, Peng W, Chen Y, Nie Y, Zhou Y, Zhou Y. Gut Microbiota Is a Potential Biomarker in Inflammatory Bowel Disease. Front Nutr 2022;8:818902. [DOI: 10.3389/fnut.2021.818902] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
88 Li R, Huang X, Yang L, Liang X, Huang W, Lai KP, Zhou L. Integrated Analysis Reveals the Targets and Mechanisms in Immunosuppressive Effect of Mesalazine on Ulcerative Colitis. Front Nutr 2022;9:867692. [DOI: 10.3389/fnut.2022.867692] [Reference Citation Analysis]
89 Luo X, Yue B, Yu Z, Ren Y, Zhang J, Ren J, Wang Z, Dou W. Obacunone Protects Against Ulcerative Colitis in Mice by Modulating Gut Microbiota, Attenuating TLR4/NF-κB Signaling Cascades, and Improving Disrupted Epithelial Barriers. Front Microbiol 2020;11:497. [PMID: 32296403 DOI: 10.3389/fmicb.2020.00497] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
90 Dubois-Deruy E, Rémy G, Alard J, Kervoaze G, Chwastyniak M, Baron M, Beury D, Siegwald L, Caboche S, Hot D, Gosset P, Grangette C, Pinet F, Wolowczuk I, Pichavant M. Modelling the Impact of Chronic Cigarette Smoke Exposure in Obese Mice: Metabolic, Pulmonary, Intestinal, and Cardiac Issues. Nutrients 2020;12:E827. [PMID: 32244932 DOI: 10.3390/nu12030827] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 Wan S, Nie Y, Zhang Y, Huang C, Zhu X. Gut Microbial Dysbiosis Is Associated With Profibrotic Factors in Liver Fibrosis Mice. Front Cell Infect Microbiol 2020;10:18. [PMID: 32083022 DOI: 10.3389/fcimb.2020.00018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
92 Song G, Fiocchi C, Achkar JP. Acupuncture in Inflammatory Bowel Disease. Inflamm Bowel Dis 2019;25:1129-39. [PMID: 30535303 DOI: 10.1093/ibd/izy371] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
93 Roy BC, Ahmed I, Stubbs J, Zhang J, Attard T, Septer S, Welch D, Anant S, Sampath V, Umar S. DCLK1 isoforms and aberrant Notch signaling in the regulation of human and murine colitis. Cell Death Discov 2021;7:169. [PMID: 34226497 DOI: 10.1038/s41420-021-00526-9] [Reference Citation Analysis]
94 Ermann J, Matmusaev M, Haley EK, Braun C, Jost F, Mayer-Wrangowski S, Hsiao P, Ting N, Li L, Terenzio D, Chime J, Lukas S, Patnaude L, Panzenbeck M, Csordas D, Zheng J, Mierz D, Simpson T, King FJ, Klimowicz AP, Mbow ML, Fine JS, Miller CA, Fogal SE, Byrne FR. The potent and selective RIPK2 inhibitor BI 706039 improves intestinal inflammation in the TRUC mouse model of inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 2021;321:G500-12. [PMID: 34494462 DOI: 10.1152/ajpgi.00163.2021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Pu D, Zhang Z, Feng B. Alterations and Potential Applications of Gut Microbiota in Biological Therapy for Inflammatory Bowel Diseases. Front Pharmacol 2022;13:906419. [DOI: 10.3389/fphar.2022.906419] [Reference Citation Analysis]
96 Saber S, Abd El-Fattah EE, Yahya G, Gobba NA, Maghmomeh AO, Khodir AE, Mourad AAE, Saad AS, Mohammed HG, Nouh NA, Shata A, Amin NA, Abou El-Rous M, Girgis S, El-Ahwany E, Khalaf EM, El-Kott AF, El-Baz AM. A Novel Combination Therapy Using Rosuvastatin and Lactobacillus Combats Dextran Sodium Sulfate-Induced Colitis in High-Fat Diet-Fed Rats by Targeting the TXNIP/NLRP3 Interaction and Influencing Gut Microbiome Composition. Pharmaceuticals (Basel) 2021;14:341. [PMID: 33917884 DOI: 10.3390/ph14040341] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
97 Gao X, Huang D, Yang LS, He AQ, Li KY, Liu T, Liu G. Identification of gut microbiome and transcriptome changes in ulcerative colitis and pouchitis. Scand J Gastroenterol 2022;:1-11. [PMID: 35275769 DOI: 10.1080/00365521.2022.2047221] [Reference Citation Analysis]
98 Pepelyayeva Y, Rastall DPW, Aldhamen YA, O'Connell P, Raehtz S, Alyaqoub FS, Blake MK, Raedy AM, Angarita AM, Abbas AM, Pereira-Hicks CN, Roosa SG, McCabe L, Amalfitano A. ERAP1 deficient mice have reduced Type 1 regulatory T cells and develop skeletal and intestinal features of Ankylosing Spondylitis. Sci Rep 2018;8:12464. [PMID: 30127455 DOI: 10.1038/s41598-018-30159-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
99 Wang G, Huang S, Cai S, Yu H, Wang Y, Zeng X, Qiao S. Lactobacillus reuteri Ameliorates Intestinal Inflammation and Modulates Gut Microbiota and Metabolic Disorders in Dextran Sulfate Sodium-Induced Colitis in Mice. Nutrients 2020;12:E2298. [PMID: 32751784 DOI: 10.3390/nu12082298] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
100 Dmochowska N, Wardill HR, Hughes PA. Advances in Imaging Specific Mediators of Inflammatory Bowel Disease. Int J Mol Sci 2018;19:E2471. [PMID: 30134572 DOI: 10.3390/ijms19092471] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
101 Soleimani D, Miryan M, Tutunchi H, Navashenaq JG, Sadeghi E, Ghayour-Mobarhan M, Ferns GA, Ostadrahimi A. A systematic review of preclinical studies on the efficacy of propolis for the treatment of inflammatory bowel disease. Phytother Res 2021;35:701-10. [PMID: 32989885 DOI: 10.1002/ptr.6856] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
102 Qu S, Fan L, Qi Y, Xu C, Hu Y, Chen S, Liu W, Liu W, Si J. Akkermansia muciniphila Alleviates Dextran Sulfate Sodium (DSS)-Induced Acute Colitis by NLRP3 Activation. Microbiol Spectr 2021;9:e0073021. [PMID: 34612661 DOI: 10.1128/Spectrum.00730-21] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
103 Gianchecchi E, Fierabracci A. Recent Advances on Microbiota Involvement in the Pathogenesis of Autoimmunity. Int J Mol Sci. 2019;20. [PMID: 30642013 DOI: 10.3390/ijms20020283] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 7.7] [Reference Citation Analysis]
104 Battistini C, Ballan R, Herkenhoff ME, Saad SMI, Sun J. Vitamin D Modulates Intestinal Microbiota in Inflammatory Bowel Diseases. Int J Mol Sci 2020;22:E362. [PMID: 33396382 DOI: 10.3390/ijms22010362] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
105 Zhu W, Yan J, Zhi C, Zhou Q, Yuan X. 1,25(OH) 2D3 deficiency-induced gut microbial dysbiosis degrades the colonic mucus barrier in Cyp27b1 knockout mouse model. Gut Pathog. 2019;11:8. [PMID: 30828386 DOI: 10.1186/s13099-019-0291-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
106 Kwong EK, Puri P. Gut microbiome changes in Nonalcoholic fatty liver disease & alcoholic liver disease. Transl Gastroenterol Hepatol 2021;6:3. [PMID: 33409398 DOI: 10.21037/tgh.2020.02.18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
107 Kameli N, Becker HEF, Welbers T, Jonkers DMAE, Penders J, Savelkoul P, Stassen FR. Metagenomic Profiling of Fecal-Derived Bacterial Membrane Vesicles in Crohn's Disease Patients. Cells 2021;10:2795. [PMID: 34685776 DOI: 10.3390/cells10102795] [Reference Citation Analysis]
108 Privitera G, Rana N, Scaldaferri F, Armuzzi A, Pizarro TT. Novel Insights Into the Interactions Between the Gut Microbiome, Inflammasomes, and Gasdermins During Colorectal Cancer. Front Cell Infect Microbiol 2022;11:806680. [DOI: 10.3389/fcimb.2021.806680] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
109 Hou K, Wu ZX, Chen XY, Wang JQ, Zhang D, Xiao C, Zhu D, Koya JB, Wei L, Li J, Chen ZS. Microbiota in health and diseases. Signal Transduct Target Ther 2022;7:135. [PMID: 35461318 DOI: 10.1038/s41392-022-00974-4] [Reference Citation Analysis]
110 Mooser C, Ganal-Vonarburg SC. Microbiota as a cornerstone in the development of primary sclerosing cholangitis: paving the path for translational diagnostic and therapeutic approaches. Gut 2019;68:1353-5. [PMID: 31028154 DOI: 10.1136/gutjnl-2019-318487] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
111 Guandalini S, Sansotta N. Probiotics in the Treatment of Inflammatory Bowel Disease. Adv Exp Med Biol 2019;1125:101-7. [PMID: 30632114 DOI: 10.1007/5584_2018_319] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
112 Rahabi M, Salon M, Bruno-Bonnet C, Prat M, Jacquemin G, Benmoussa K, Alaeddine M, Parny M, Bernad J, Bertrand B, Auffret Y, Robert-Jolimaître P, Alric L, Authier H, Coste A. Bioactive fish collagen peptides weaken intestinal inflammation by orienting colonic macrophages phenotype through mannose receptor activation. Eur J Nutr 2022. [PMID: 34999930 DOI: 10.1007/s00394-021-02787-7] [Reference Citation Analysis]
113 Mukhopadhya I, Segal JP, Carding SR, Hart AL, Hold GL. The gut virome: the 'missing link' between gut bacteria and host immunity? Therap Adv Gastroenterol 2019;12:1756284819836620. [PMID: 30936943 DOI: 10.1177/1756284819836620] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 18.3] [Reference Citation Analysis]
114 Wawrzyniak P, Noureddine N, Wawrzyniak M, Lucchinetti E, Krämer SD, Rogler G, Zaugg M, Hersberger M. Nutritional Lipids and Mucosal Inflammation. Mol Nutr Food Res 2021;65:e1901269. [PMID: 32780927 DOI: 10.1002/mnfr.201901269] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
115 Banfi D, Moro E, Bosi A, Bistoletti M, Cerantola S, Crema F, Maggi F, Giron MC, Giaroni C, Baj A. Impact of Microbial Metabolites on Microbiota-Gut-Brain Axis in Inflammatory Bowel Disease. Int J Mol Sci 2021;22:1623. [PMID: 33562721 DOI: 10.3390/ijms22041623] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
116 Kriaa A, Mariaule V, Jablaoui A, Rhimi S, Mkaouar H, Hernandez J, Korkmaz B, Lesner A, Maguin E, Aghdassi A, Rhimi M. Bile Acids: Key Players in Inflammatory Bowel Diseases? Cells 2022;11:901. [DOI: 10.3390/cells11050901] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
117 Krela-Kaźmierczak I, Zakerska-Banaszak O, Skrzypczak-Zielińska M, Łykowska-Szuber L, Szymczak-Tomczak A, Zawada A, Rychter AM, Ratajczak AE, Skoracka K, Skrzypczak D, Marcinkowska E, Słomski R, Dobrowolska A. Where Do We Stand in the Behavioral Pathogenesis of Inflammatory Bowel Disease? The Western Dietary Pattern and Microbiota-A Narrative Review. Nutrients 2022;14:2520. [PMID: 35745251 DOI: 10.3390/nu14122520] [Reference Citation Analysis]
118 Qv L, Mao S, Li Y, Zhang J, Li L. Roles of Gut Bacteriophages in the Pathogenesis and Treatment of Inflammatory Bowel Disease. Front Cell Infect Microbiol 2021;11:755650. [PMID: 34900751 DOI: 10.3389/fcimb.2021.755650] [Reference Citation Analysis]
119 Zhang Y, Wu Z, Liu J, Zheng Z, Li Q, Wang H, Chen Z, Wang K. Identification of the core active structure of a Dendrobium officinale polysaccharide and its protective effect against dextran sulfate sodium-induced colitis via alleviating gut microbiota dysbiosis. Food Res Int 2020;137:109641. [PMID: 33233220 DOI: 10.1016/j.foodres.2020.109641] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
120 Segal JP, Mullish BH, Quraishi MN, Acharjee A, Williams HRT, Iqbal T, Hart AL, Marchesi JR. The application of omics techniques to understand the role of the gut microbiota in inflammatory bowel disease. Therap Adv Gastroenterol 2019;12:1756284818822250. [PMID: 30719076 DOI: 10.1177/1756284818822250] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 8.7] [Reference Citation Analysis]
121 Tauzin AS, Pereira MR, Van Vliet LD, Colin PY, Laville E, Esque J, Laguerre S, Henrissat B, Terrapon N, Lombard V, Leclerc M, Doré J, Hollfelder F, Potocki-Veronese G. Investigating host-microbiome interactions by droplet based microfluidics. Microbiome 2020;8:141. [PMID: 33004077 DOI: 10.1186/s40168-020-00911-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
122 Guillamón E, Andreo-Martínez P, Mut-Salud N, Fonollá J, Baños A. Beneficial Effects of Organosulfur Compounds from Allium cepa on Gut Health: A Systematic Review. Foods 2021;10:1680. [PMID: 34441457 DOI: 10.3390/foods10081680] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
123 Guo Y, Xu C, Gong R, Hu T, Zhang X, Xie X, Chi J, Li H, Xia X, Liu X. Exosomal CagA from Helicobacter pylori aggravates intestinal epithelium barrier dysfunction in chronic colitis by facilitating Claudin-2 expression. Gut Pathog 2022;14:13. [PMID: 35331316 DOI: 10.1186/s13099-022-00486-0] [Reference Citation Analysis]
124 Azimirad M, Krutova M, Balaii H, Kodori M, Shahrokh S, Azizi O, Yadegar A, Aghdaei HA, Zali MR. Coexistence of Clostridioides difficile and Staphylococcus aureus in gut of Iranian outpatients with underlying inflammatory bowel disease. Anaerobe 2020;61:102113. [DOI: 10.1016/j.anaerobe.2019.102113] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
125 Abuqwider J, Altamimi M, Mauriello G. Limosilactobacillus reuteri in Health and Disease. Microorganisms 2022;10:522. [DOI: 10.3390/microorganisms10030522] [Reference Citation Analysis]
126 Tuddenham S, Koay WL, Sears C. HIV, Sexual Orientation, and Gut Microbiome Interactions. Dig Dis Sci 2020;65:800-17. [PMID: 32030625 DOI: 10.1007/s10620-020-06110-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
127 Guan Q. A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease. J Immunol Res 2019;2019:7247238. [PMID: 31886308 DOI: 10.1155/2019/7247238] [Cited by in Crossref: 95] [Cited by in F6Publishing: 90] [Article Influence: 31.7] [Reference Citation Analysis]
128 Edwards V, Smith DL, Meylan F, Tiffany L, Poncet S, Wu WW, Phue JN, Santana-Quintero L, Clouse KA, Gabay O. Analyzing the Role of Gut Microbiota on the Onset of Autoimmune Diseases Using TNFΔARE Murine Model. Microorganisms 2021;10:73. [PMID: 35056521 DOI: 10.3390/microorganisms10010073] [Reference Citation Analysis]
129 Zhu X, Bi Z, Yang C, Guo Y, Yuan J, Li L, Guo Y. Effects of different doses of omega-3 polyunsaturated fatty acids on gut microbiota and immunity. Food Nutr Res 2021;65. [PMID: 34349613 DOI: 10.29219/fnr.v65.6263] [Reference Citation Analysis]
130 Akobeng AK, Singh P, Kumar M, Al Khodor S. Role of the gut microbiota in the pathogenesis of coeliac disease and potential therapeutic implications. Eur J Nutr 2020;59:3369-90. [PMID: 32651763 DOI: 10.1007/s00394-020-02324-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
131 Alonso R, Pisa D, Fernández-Fernández AM, Carrasco L. Infection of Fungi and Bacteria in Brain Tissue From Elderly Persons and Patients With Alzheimer's Disease. Front Aging Neurosci 2018;10:159. [PMID: 29881346 DOI: 10.3389/fnagi.2018.00159] [Cited by in Crossref: 58] [Cited by in F6Publishing: 48] [Article Influence: 14.5] [Reference Citation Analysis]
132 Zuo T, Lu XJ, Zhang Y, Cheung CP, Lam S, Zhang F, Tang W, Ching JYL, Zhao R, Chan PKS, Sung JJY, Yu J, Chan FKL, Cao Q, Sheng JQ, Ng SC. Gut mucosal virome alterations in ulcerative colitis. Gut 2019;68:1169-79. [PMID: 30842211 DOI: 10.1136/gutjnl-2018-318131] [Cited by in Crossref: 142] [Cited by in F6Publishing: 115] [Article Influence: 47.3] [Reference Citation Analysis]
133 Bajaj JS. Alcohol, liver disease and the gut microbiota. Nat Rev Gastroenterol Hepatol 2019;16:235-46. [DOI: 10.1038/s41575-018-0099-1] [Cited by in Crossref: 122] [Cited by in F6Publishing: 120] [Article Influence: 40.7] [Reference Citation Analysis]
134 Zhai L, Peng J, Zhuang M, Chang Y, Cheng KW, Ning Z, Huang T, Lin C, Wong HLX, Lam YY, Tan HY, Xiao H, Bian Z. Therapeutic effects and mechanisms of Zhen-Wu-Bu-Qi Decoction on dextran sulfate sodium-induced chronic colitis in mice assessed by multi-omics approaches. Phytomedicine 2022. [DOI: 10.1016/j.phymed.2022.154001] [Reference Citation Analysis]
135 Tuddenham SA, Koay WLA, Zhao N, White JR, Ghanem KG, Sears CL; HIV Microbiome Re-analysis Consortium. The Impact of Human Immunodeficiency Virus Infection on Gut Microbiota α-Diversity: An Individual-level Meta-analysis. Clin Infect Dis 2020;70:615-27. [PMID: 30921452 DOI: 10.1093/cid/ciz258] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 24.0] [Reference Citation Analysis]
136 Takahara M, Takaki A, Hiraoka S, Takei K, Yasutomi E, Igawa S, Yamamoto S, Oka S, Ohmori M, Yamasaki Y, Inokuchi T, Kinugasa H, Harada K, Udono H, Okada H. Metformin ameliorates chronic colitis in a mouse model by regulating interferon‐γ‐producing lamina propria CD4 + T cells through AMPK activation. The FASEB Journal 2022;36. [DOI: 10.1096/fj.202100831rr] [Reference Citation Analysis]
137 Pazmandi J, Kalinichenko A, Ardy RC, Boztug K. Early-onset inflammatory bowel disease as a model disease to identify key regulators of immune homeostasis mechanisms. Immunol Rev 2019;287:162-85. [PMID: 30565237 DOI: 10.1111/imr.12726] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
138 Tarris G, de Rougemont A, Estienney M, Charkaoui M, Mouillot T, Bonnotte B, Michiels C, Martin L, Belliot G. Specific Norovirus Interaction with Lewis x and Lewis a on Human Intestinal Inflammatory Mucosa during Refractory Inflammatory Bowel Disease. mSphere 2021;6:e01185-20. [PMID: 33441404 DOI: 10.1128/mSphere.01185-20] [Reference Citation Analysis]
139 Muller M, Hansmannel F, Arnone D, Choukour M, Ndiaye NC, Kokten T, Houlgatte R, Peyrin-Biroulet L. Genomic and molecular alterations in human inflammatory bowel disease-associated colorectal cancer. United European Gastroenterol J 2020;8:675-84. [PMID: 32268844 DOI: 10.1177/2050640620919254] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
140 Zeng X, Jia H, Shi Y, Chen K, Wang Z, Gao Z, Yuan Y, Yue T. Lactobacillus kefiranofaciens JKSP109 and Saccharomyces cerevisiae JKSP39 isolated from Tibetan kefir grain co-alleviated AOM/DSS induced inflammation and colorectal carcinogenesis. Food Funct 2022. [PMID: 35575226 DOI: 10.1039/d1fo02939h] [Reference Citation Analysis]
141 Khan I, Ullah N, Zha L, Bai Y, Khan A, Zhao T, Che T, Zhang C. Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome. Pathogens 2019;8:E126. [PMID: 31412603 DOI: 10.3390/pathogens8030126] [Cited by in Crossref: 127] [Cited by in F6Publishing: 113] [Article Influence: 42.3] [Reference Citation Analysis]
142 Xu F, Cheng Y, Ruan G, Fan L, Tian Y, Xiao Z, Chen D, Wei Y. New pathway ameliorating ulcerative colitis: focus on Roseburia intestinalis and the gut-brain axis. Therap Adv Gastroenterol 2021;14:17562848211004469. [PMID: 33948112 DOI: 10.1177/17562848211004469] [Reference Citation Analysis]
143 Mannion A, Shen Z, Feng Y, Puglisi D, Muthupalani S, Whary MT, Fox JG. Natural Transmission of Helicobacter saguini Causes Multigenerational Inflammatory Bowel Disease in C57/129 IL-10-/- Mice. mSphere 2020;5:e00011-20. [PMID: 32213619 DOI: 10.1128/mSphere.00011-20] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
144 Tong L, Zhang X, Hao H, Liu Q, Zhou Z, Liang X, Liu T, Gong P, Zhang L, Zhai Z, Hao Y, Yi H. Lactobacillus rhamnosus GG Derived Extracellular Vesicles Modulate Gut Microbiota and Attenuate Inflammatory in DSS-Induced Colitis Mice. Nutrients 2021;13:3319. [PMID: 34684320 DOI: 10.3390/nu13103319] [Reference Citation Analysis]
145 Kitabatake M, Matsumura Y, Ouji-Sageshima N, Nishioka T, Hara A, Kayano SI, Ito T. Persimmon-derived tannin ameliorates the pathogenesis of ulcerative colitis in a murine model through inhibition of the inflammatory response and alteration of microbiota. Sci Rep 2021;11:7286. [PMID: 33790314 DOI: 10.1038/s41598-021-86608-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
146 Son HJ, Kim N, Song CH, Nam RH, Choi SI, Kim JS, Lee DH. Sex-related Alterations of Gut Microbiota in the C57BL/6 Mouse Model of Inflammatory Bowel Disease. J Cancer Prev 2019;24:173-82. [PMID: 31624723 DOI: 10.15430/JCP.2019.24.3.173] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
147 Sinagra E, Pellegatta G, Guarnotta V, Maida M, Rossi F, Conoscenti G, Pallio S, Alloro R, Raimondo D, Pace F, Anderloni A. Microbiota Gut-Brain Axis in Ischemic Stroke: A Narrative Review with a Focus about the Relationship with Inflammatory Bowel Disease. Life (Basel) 2021;11:715. [PMID: 34357086 DOI: 10.3390/life11070715] [Reference Citation Analysis]
148 Linnér A, Almgren M. Epigenetic programming-The important first 1000 days. Acta Paediatr 2020;109:443-52. [PMID: 31603247 DOI: 10.1111/apa.15050] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 13.0] [Reference Citation Analysis]
149 Cheng L, Kaźmierczak D, Norenhag J, Hamsten M, Fransson E, Schuppe-Koistinen I, Olovsson M, Engstrand L, Hydbring P, Du J. A MicroRNA Gene Panel Predicts the Vaginal Microbiota Composition. mSystems 2021;6:e00175-21. [PMID: 33947805 DOI: 10.1128/mSystems.00175-21] [Reference Citation Analysis]
150 Ali F, Lui K, Wang A, Day AS, Leach ST. The perinatal period, the developing intestinal microbiome and inflammatory bowel diseases: What links early life events with later life disease? Journal of the Royal Society of New Zealand 2020;50:371-83. [DOI: 10.1080/03036758.2019.1706586] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
151 Lu SY, Liu Y, Tang S, Zhang W, Yu Q, Shi C, Cheong KL. Gracilaria lemaneiformis polysaccharides alleviate colitis by modulating the gut microbiota and intestinal barrier in mice. Food Chem X 2022;13:100197. [PMID: 35498989 DOI: 10.1016/j.fochx.2021.100197] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
152 Vicentini FA, Keenan CM, Wallace LE, Woods C, Cavin JB, Flockton AR, Macklin WB, Belkind-Gerson J, Hirota SA, Sharkey KA. Intestinal microbiota shapes gut physiology and regulates enteric neurons and glia. Microbiome 2021;9:210. [PMID: 34702353 DOI: 10.1186/s40168-021-01165-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
153 Lee SY, Lee BH, Park JH, Park MS, Ji GE, Sung MK. Bifidobacterium bifidum BGN4 Paraprobiotic Supplementation Alleviates Experimental Colitis by Maintaining Gut Barrier and Suppressing Nuclear Factor Kappa B Activation Signaling Molecules. J Med Food 2022;25:146-57. [PMID: 35148194 DOI: 10.1089/jmf.2021.K.0150] [Reference Citation Analysis]
154 Mironova OI, Isaikina MA, Khasieva SA. Аtherosclerosis and cardiovascular risk in patients with inflammatory bowel disease. Terapevticheskii arkhiv 2022;93:1533-8. [DOI: 10.26442/00403660.2021.12.201225] [Reference Citation Analysis]
155 Ruan W, Engevik MA, Spinler JK, Versalovic J. Healthy Human Gastrointestinal Microbiome: Composition and Function After a Decade of Exploration. Dig Dis Sci 2020;65:695-705. [PMID: 32067143 DOI: 10.1007/s10620-020-06118-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
156 Imai J, Kitamoto S, Kamada N. The pathogenic oral-gut-liver axis: new understandings and clinical implications. Expert Rev Clin Immunol 2021;17:727-36. [PMID: 34057877 DOI: 10.1080/1744666X.2021.1935877] [Reference Citation Analysis]
157 Ou W, Hu H, Yang P, Dai J, Ai Q, Zhang W, Zhang Y, Mai K. Dietary daidzein improved intestinal health of juvenile turbot in terms of intestinal mucosal barrier function and intestinal microbiota. Fish Shellfish Immunol 2019;94:132-41. [PMID: 31461659 DOI: 10.1016/j.fsi.2019.08.059] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
158 García-Durán C, Martínez-López R, Monteoliva L, Gil C. Sample Processing for Metaproteomic Analysis of Human Gut Microbiota. Methods Mol Biol 2022;2420:53-61. [PMID: 34905165 DOI: 10.1007/978-1-0716-1936-0_5] [Reference Citation Analysis]
159 Cao SS. Cellular Stress Responses and Gut Microbiota in Inflammatory Bowel Disease. Gastroenterol Res Pract. 2018;2018:7192646. [PMID: 30026758 DOI: 10.1155/2018/7192646] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
160 Das A, O'Herlihy E, Shanahan F, O'Toole PW, Jeffery IB. The fecal mycobiome in patients with Irritable Bowel Syndrome. Sci Rep 2021;11:124. [PMID: 33420127 DOI: 10.1038/s41598-020-79478-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
161 Majta J, Odrzywolek K, Milanovic B, Hubar V, Wrobel S, Strycharz-Angrecka E, Wojciechowski S, Milanowska K. Identification of Differentiating Metabolic Pathways between Infant Gut Microbiome Populations Reveals Depletion of Function-Level Adaptation to Human Milk in the Finnish Population. mSphere 2019;4:e00152-19. [PMID: 30894435 DOI: 10.1128/mSphereDirect.00152-19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
162 Wu H, Ye L, Lu X, Xie S, Yang Q, Yu Q. Lactobacillus acidophilus Alleviated Salmonella-Induced Goblet Cells Loss and Colitis by Notch Pathway. Mol Nutr Food Res 2018;62:e1800552. [PMID: 30198100 DOI: 10.1002/mnfr.201800552] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
163 Dong F, Perdew GH. The aryl hydrocarbon receptor as a mediator of host-microbiota interplay. Gut Microbes 2020;12:1859812. [PMID: 33382356 DOI: 10.1080/19490976.2020.1859812] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
164 Ihekweazu FD, Engevik MA, Ruan W, Shi Z, Fultz R, Engevik KA, Chang-Graham AL, Freeborn J, Park ES, Venable S, Horvath TD, Haidacher SJ, Haag AM, Goodwin A, Schady DA, Hyser JM, Spinler JK, Liu Y, Versalovic J. Bacteroides ovatus Promotes IL-22 Production and Reduces Trinitrobenzene Sulfonic Acid-Driven Colonic Inflammation. Am J Pathol 2021;191:704-19. [PMID: 33516788 DOI: 10.1016/j.ajpath.2021.01.009] [Reference Citation Analysis]
165 Alshehri D, Saadah O, Mosli M, Edris S, Alhindi R, Bahieldin A. Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches. Bosn J Basic Med Sci 2021;21:270-83. [PMID: 33052081 DOI: 10.17305/bjbms.2020.5016] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
166 Yamashita T, Tai S, Tsukahara T, Inoue R. Fusobacterium nucleatum impedes remission of colitis in a mouse model. Biosci Biotechnol Biochem 2021;85:1235-42. [PMID: 33674867 DOI: 10.1093/bbb/zbab029] [Reference Citation Analysis]
167 Zhong Y, Kang Z, Wang M, Long J, Wang H, Huang J, Wei S, Zhou W, Zhao H, Liu D. Curcumin ameliorated dextran sulfate sodium-induced colitis via regulating the homeostasis of DCs and Treg and improving the composition of the gut microbiota. Journal of Functional Foods 2021;86:104716. [DOI: 10.1016/j.jff.2021.104716] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
168 Li H, Shi J, Zhao L, Guan J, Liu F, Huo G, Li B. Lactobacillus plantarum KLDS1.0344 and Lactobacillus acidophilus KLDS1.0901 Mixture Prevents Chronic Alcoholic Liver Injury in Mice by Protecting the Intestinal Barrier and Regulating Gut Microbiota and Liver-Related Pathways. J Agric Food Chem 2021;69:183-97. [PMID: 33353302 DOI: 10.1021/acs.jafc.0c06346] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
169 Corridoni D, Chapman T, Antanaviciute A, Satsangi J, Simmons A. Inflammatory Bowel Disease Through the Lens of Single-cell RNA-seq Technologies. Inflammatory Bowel Diseases 2020;26:1658-68. [DOI: 10.1093/ibd/izaa089] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
170 Malesza IJ, Malesza M, Walkowiak J, Mussin N, Walkowiak D, Aringazina R, Bartkowiak-Wieczorek J, Mądry E. High-Fat, Western-Style Diet, Systemic Inflammation, and Gut Microbiota: A Narrative Review. Cells 2021;10:3164. [PMID: 34831387 DOI: 10.3390/cells10113164] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
171 Fousekis FS, Katsanos AH, Kourtis G, Saridi M, Albani E, Katsanos KH, Christodoulou DK. Inflammatory Bowel Disease and Patients With Mental Disorders: What Do We Know? J Clin Med Res 2021;13:466-73. [PMID: 34691320 DOI: 10.14740/jocmr4593] [Reference Citation Analysis]
172 Zhang Y, Liu W, Zhang D, Yang Y, Wang X, Li L. Fermented and Germinated Processing Improved the Protective Effects of Foxtail Millet Whole Grain Against Dextran Sulfate Sodium-Induced Acute Ulcerative Colitis and Gut Microbiota Dysbiosis in C57BL/6 Mice. Front Nutr 2021;8:694936. [PMID: 34395495 DOI: 10.3389/fnut.2021.694936] [Reference Citation Analysis]
173 Chen W, Chen H, Fu S, Lin X, Zheng Z, Zhang J. Microbiome characterization and re-design by biologic agents for inflammatory bowel disease insights. Bioprocess Biosyst Eng 2021;44:929-39. [PMID: 32458051 DOI: 10.1007/s00449-020-02380-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
174 Liu P, Bian Y, Liu T, Zhong J, Zhong Y, Zhuang S, Liu Z. Huai hua san alleviates dextran sulphate sodium-induced colitis and modulates colonic microbiota. J Ethnopharmacol 2020;259:112944. [PMID: 32387236 DOI: 10.1016/j.jep.2020.112944] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
175 Chen S, Wu X, Tang S, Yin J, Song Z, He X, Yin Y. Eugenol Alleviates Dextran Sulfate Sodium-Induced Colitis Independent of Intestinal Microbiota in Mice. J Agric Food Chem 2021;69:10506-14. [PMID: 34478286 DOI: 10.1021/acs.jafc.1c00917] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
176 Yeo S, Park H, Seo E, Kim J, Kim BK, Choi IS, Huh CS. Anti-Inflammatory and Gut Microbiota Modulatory Effect of Lactobacillus rhamnosus Strain LDTM 7511 in a Dextran Sulfate Sodium-Induced Colitis Murine Model. Microorganisms 2020;8:E845. [PMID: 32512895 DOI: 10.3390/microorganisms8060845] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
177 Fackelmann G, Sommer S. Microplastics and the gut microbiome: How chronically exposed species may suffer from gut dysbiosis. Mar Pollut Bull 2019;143:193-203. [PMID: 31789155 DOI: 10.1016/j.marpolbul.2019.04.030] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 18.7] [Reference Citation Analysis]
178 Xu N, Bai X, Cao X, Yue W, Jiang W, Yu Z. Changes in intestinal microbiota and correlation with TLRs in ulcerative colitis in the coastal area of northern China. Microb Pathog 2021;150:104707. [PMID: 33352216 DOI: 10.1016/j.micpath.2020.104707] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
179 Bilski J, Wojcik D, Danielak A, Mazur-bialy A, Magierowski M, Tønnesen K, Brzozowski B, Surmiak M, Magierowska K, Pajdo R, Ptak-belowska A, Brzozowski T. Alternative Therapy in the Prevention of Experimental and Clinical Inflammatory Bowel Disease. Impact of Regular Physical Activity, Intestinal Alkaline Phosphatase and Herbal Products. CPD 2020;26:2936-50. [DOI: 10.2174/1381612826666200427090127] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
180 Jones E, Stentz R, Telatin A, Savva GM, Booth C, Baker D, Rudder S, Knight SC, Noble A, Carding SR. The Origin of Plasma-Derived Bacterial Extracellular Vesicles in Healthy Individuals and Patients with Inflammatory Bowel Disease: A Pilot Study. Genes (Basel) 2021;12:1636. [PMID: 34681030 DOI: 10.3390/genes12101636] [Reference Citation Analysis]
181 Papoutsopoulou S, Satsangi J, Campbell BJ, Probert CS. Review article: impact of cigarette smoking on intestinal inflammation-direct and indirect mechanisms. Aliment Pharmacol Ther 2020;51:1268-85. [PMID: 32372449 DOI: 10.1111/apt.15774] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
182 Park YE, Moon HS, Yong D, Seo H, Yang J, Shin TS, Kim YK, Kim JR, Lee YN, Kim YH, Kim JS, Cheon JH. Microbial changes in stool, saliva, serum, and urine before and after anti-TNF-α therapy in patients with inflammatory bowel diseases. Sci Rep 2022;12:6359. [PMID: 35428806 DOI: 10.1038/s41598-022-10450-2] [Reference Citation Analysis]
183 Lin R, Li D, Xu Y, Wei M, Chen Q, Deng Y, Wen J. Chronic cereulide exposure causes intestinal inflammation and gut microbiota dysbiosis in mice. Environ Pollut 2021;288:117814. [PMID: 34329069 DOI: 10.1016/j.envpol.2021.117814] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
184 Bosi A, Banfi D, Bistoletti M, Moretto P, Moro E, Crema F, Maggi F, Karousou E, Viola M, Passi A, Vigetti D, Giaroni C, Baj A. Hyaluronan: A Neuroimmune Modulator in the Microbiota-Gut Axis. Cells 2021;11:126. [PMID: 35011688 DOI: 10.3390/cells11010126] [Reference Citation Analysis]
185 Khor B, Snow M, Herrman E, Ray N, Mansukhani K, Patel KA, Said-Al-Naief N, Maier T, Machida CA. Interconnections Between the Oral and Gut Microbiomes: Reversal of Microbial Dysbiosis and the Balance Between Systemic Health and Disease. Microorganisms 2021;9:496. [PMID: 33652903 DOI: 10.3390/microorganisms9030496] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
186 Panelli S, Epis S, Cococcioni L, Perini M, Paroni M, Bandi C, Drago L, Zuccotti GV. Inflammatory bowel diseases, the hygiene hypothesis and the other side of the microbiota: Parasites and fungi. Pharmacol Res 2020;159:104962. [PMID: 32480001 DOI: 10.1016/j.phrs.2020.104962] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
187 Rattan P, Minacapelli CD, Rustgi V. The Microbiome and Hepatocellular Carcinoma. Liver Transpl. 2020;26:1316-1327. [PMID: 32564483 DOI: 10.1002/lt.25828] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
188 Wu J, Wei Z, Cheng P, Qian C, Xu F, Yang Y, Wang A, Chen W, Sun Z, Lu Y. Rhein modulates host purine metabolism in intestine through gut microbiota and ameliorates experimental colitis. Theranostics 2020;10:10665-79. [PMID: 32929373 DOI: 10.7150/thno.43528] [Cited by in Crossref: 47] [Cited by in F6Publishing: 35] [Article Influence: 23.5] [Reference Citation Analysis]
189 De Filippis F, Vitaglione P, Cuomo R, Berni Canani R, Ercolini D. Dietary Interventions to Modulate the Gut Microbiome-How Far Away Are We From Precision Medicine. Inflamm Bowel Dis 2018;24:2142-54. [PMID: 29668914 DOI: 10.1093/ibd/izy080] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 13.0] [Reference Citation Analysis]
190 Cai Z, Zhu T, Liu F, Zhuang Z, Zhao L. Co-pathogens in Periodontitis and Inflammatory Bowel Disease. Front Med (Lausanne) 2021;8:723719. [PMID: 34616755 DOI: 10.3389/fmed.2021.723719] [Reference Citation Analysis]
191 Mandl T, Marsal J, Olsson P, Ohlsson B, Andréasson K. Severe intestinal dysbiosis is prevalent in primary Sjögren's syndrome and is associated with systemic disease activity. Arthritis Res Ther 2017;19:237. [PMID: 29065905 DOI: 10.1186/s13075-017-1446-2] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 8.4] [Reference Citation Analysis]
192 Baruch EN, Gaglani T, Wargo JA. Fecal microbiota transplantation as a mean of overcoming immunotherapy-resistant cancers - hype or hope? Ther Adv Med Oncol 2021;13:17588359211045853. [PMID: 34603515 DOI: 10.1177/17588359211045853] [Reference Citation Analysis]
193 Britton GJ, Contijoch EJ, Mogno I, Vennaro OH, Llewellyn SR, Ng R, Li Z, Mortha A, Merad M, Das A, Gevers D, McGovern DPB, Singh N, Braun J, Jacobs JP, Clemente JC, Grinspan A, Sands BE, Colombel JF, Dubinsky MC, Faith JJ. Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORγt+ Regulatory T Cells and Exacerbate Colitis in Mice. Immunity 2019;50:212-224.e4. [PMID: 30650377 DOI: 10.1016/j.immuni.2018.12.015] [Cited by in Crossref: 132] [Cited by in F6Publishing: 130] [Article Influence: 44.0] [Reference Citation Analysis]
194 Stensvold CR, van der Giezen M. Associations between Gut Microbiota and Common Luminal Intestinal Parasites. Trends in Parasitology 2018;34:369-77. [DOI: 10.1016/j.pt.2018.02.004] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 14.8] [Reference Citation Analysis]
195 Tomczyk-Warunek A, Blicharski T, Muszyński S, Tomaszewska E, Dobrowolski P, Blicharski R, Jarecki J, Arczewska-Włosek A, Świątkiewicz S, Józefiak D. Structural Changes in Trabecular Bone, Cortical Bone and Hyaline Cartilage as Well as Disturbances in Bone Metabolism and Mineralization in an Animal Model of Secondary Osteoporosis in Clostridium perfringens Infection. J Clin Med 2021;11:205. [PMID: 35011946 DOI: 10.3390/jcm11010205] [Reference Citation Analysis]
196 Perumal K, Ahmad S, Mohd-zahid MH, Wan Hanaffi WN, Z.a. I, Six J, Ferji K, Jaafar J, Boer JC, Plebanski M, Uskoković V, Mohamud R. Nanoparticles and Gut Microbiota in Colorectal Cancer. Front Nanotechnol 2021;3:681760. [DOI: 10.3389/fnano.2021.681760] [Reference Citation Analysis]
197 Kousgaard SJ, Michaelsen TY, Nielsen HL, Kirk KF, Albertsen M, Thorlacius-Ussing O. The Microbiota Profile in Inflamed and Non-Inflamed Ileal Pouch-Anal Anastomosis. Microorganisms 2020;8:E1611. [PMID: 33092101 DOI: 10.3390/microorganisms8101611] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
198 Ananthakrishnan AN, Kaplan GG, Ng SC. Changing Global Epidemiology of Inflammatory Bowel Diseases: Sustaining Health Care Delivery Into the 21st Century. Clinical Gastroenterology and Hepatology 2020;18:1252-60. [DOI: 10.1016/j.cgh.2020.01.028] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 19.0] [Reference Citation Analysis]
199 Heimesaat MM, Genger C, Biesemeier N, Klove S, Weschka D, Mousavi S, Bereswill S. Inflammatory Immune Responses and Gut Microbiota Changes Following Campylobacter coli Infection of IL-10-/- Mice with Chronic Colitis. Pathogens 2020;9:E560. [PMID: 32664563 DOI: 10.3390/pathogens9070560] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
200 Seo SH, Unno T, Park SE, Kim EJ, Lee YM, Na CS, Son HS. Korean Traditional Medicine (Jakyakgamcho-tang) Ameliorates Colitis by Regulating Gut Microbiota. Metabolites 2019;9:E226. [PMID: 31615012 DOI: 10.3390/metabo9100226] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
201 Ferrer M, Aguilera M, Martinez V. Effects of Rifaximin on Luminal and Wall-Adhered Gut Commensal Microbiota in Mice. Int J Mol Sci 2021;22:E500. [PMID: 33419066 DOI: 10.3390/ijms22020500] [Reference Citation Analysis]
202 Lee M, Chang EB. Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues. Gastroenterology 2021;160:524-37. [PMID: 33253681 DOI: 10.1053/j.gastro.2020.09.056] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
203 Lee HY, Lee SH, Min KJ. The Increased Abundance of Commensal Microbes Decreases Drosophila melanogaster Lifespan through an Age-Related Intestinal Barrier Dysfunction. Insects 2022;13:219. [PMID: 35206792 DOI: 10.3390/insects13020219] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
204 Jin Y, Dong H, Xia L, Yang Y, Zhu Y, Shen Y, Zheng H, Yao C, Wang Y, Lu S. The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti-Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC. J Thorac Oncol. 2019;14:1378-1389. [PMID: 31026576 DOI: 10.1016/j.jtho.2019.04.007] [Cited by in Crossref: 90] [Cited by in F6Publishing: 104] [Article Influence: 30.0] [Reference Citation Analysis]
205 Zhuge A, Li B, Yuan Y, Lv L, Li Y, Wu J, Yang L, Bian X, Wang K, Wang Q, Yan R, Zhu X, Li L. Lactobacillus salivarius LI01 encapsulated in alginate-pectin microgels ameliorates D-galactosamine-induced acute liver injury in rats. Appl Microbiol Biotechnol 2020;104:7437-55. [PMID: 32666187 DOI: 10.1007/s00253-020-10749-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
206 Ke S, Mitchell SJ, MacArthur MR, Kane AE, Sinclair DA, Venable EM, Chadaideh KS, Carmody RN, Grodstein F, Mitchell JR, Liu Y. Gut Microbiota Predicts Healthy Late-Life Aging in Male Mice. Nutrients 2021;13:3290. [PMID: 34579167 DOI: 10.3390/nu13093290] [Reference Citation Analysis]
207 Li M, Zhang R, Li J, Li J. The Role of C-Type Lectin Receptor Signaling in the Intestinal Microbiota-Inflammation-Cancer Axis. Front Immunol 2022;13:894445. [PMID: 35619716 DOI: 10.3389/fimmu.2022.894445] [Reference Citation Analysis]
208 Hu S, Li S, Liu Y, Sun K, Luo L, Zeng L. Aged Ripe Pu-erh Tea Reduced Oxidative Stress-Mediated Inflammation in Dextran Sulfate Sodium-Induced Colitis Mice by Regulating Intestinal Microbes. J Agric Food Chem 2021;69:10592-605. [PMID: 34460244 DOI: 10.1021/acs.jafc.1c04032] [Reference Citation Analysis]
209 Singh A, Cresci GA, Kirby DF. Proton Pump Inhibitors: Risks and Rewards and Emerging Consequences to the Gut Microbiome. Nutr Clin Pract. 2018;33:614-624. [PMID: 30071147 DOI: 10.1002/ncp.10181] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
210 Zhou Y, He Y, Liu L, Zhou W, Wang P, Hu H, Nie Y, Chen Y. Alterations in Gut Microbial Communities Across Anatomical Locations in Inflammatory Bowel Diseases. Front Nutr 2021;8:615064. [PMID: 33718417 DOI: 10.3389/fnut.2021.615064] [Reference Citation Analysis]
211 Ding Y, Wang K, Xu C, Hao M, Li H, Ding L. Intestinal Claudin-7 deficiency impacts the intestinal microbiota in mice with colitis. BMC Gastroenterol 2022;22:24. [PMID: 35039003 DOI: 10.1186/s12876-022-02100-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
212 Huang J, Wen B, Zhu J, Zhang Y, Gao J, Chen Z. Exposure to microplastics impairs digestive performance, stimulates immune response and induces microbiota dysbiosis in the gut of juvenile guppy (Poecilia reticulata). Science of The Total Environment 2020;733:138929. [DOI: 10.1016/j.scitotenv.2020.138929] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 14.0] [Reference Citation Analysis]
213 Henriksson G, Bredberg J, Wullt M, Lyrenäs E, Hindorf U, Ohlsson B, Grip O. Humoral response to Clostridium difficile in inflammatory bowel disease, including correlation with immunomodulatory treatment. JGH Open 2019;3:154-8. [PMID: 31061891 DOI: 10.1002/jgh3.12122] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
214 Mandour M, Chen S, van de Sande MGH. The Role of the IL-23/IL-17 Axis in Disease Initiation in Spondyloarthritis: Lessons Learned From Animal Models. Front Immunol 2021;12:618581. [PMID: 34267743 DOI: 10.3389/fimmu.2021.618581] [Reference Citation Analysis]
215 Kuo SM. Does Modification of the Large Intestinal Microbiome Contribute to the Anti-Inflammatory Activity of Fermentable Fiber? Curr Dev Nutr 2018;2:nzx004. [PMID: 30377676 DOI: 10.3945/cdn.117.001180] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
216 Yuan X, Chen B, Duan Z, Xia Z, Ding Y, Chen T, Liu H, Wang B, Yang B, Wang X, Liu S, Zhou JY, Liu Y, Wang Q, Shen Z, Xiao J, Shang H, Liu W, Shi G, Zhu L, Chen Y. Depression and anxiety in patients with active ulcerative colitis: crosstalk of gut microbiota, metabolomics and proteomics. Gut Microbes 2021;13:1987779. [PMID: 34806521 DOI: 10.1080/19490976.2021.1987779] [Reference Citation Analysis]
217 Worby CJ, Schreiber HL 4th, Straub TJ, van Dijk LR, Bronson RA, Olson BS, Pinkner JS, Obernuefemann CLP, Muñoz VL, Paharik AE, Azimzadeh PN, Walker BJ, Desjardins CA, Chou WC, Bergeron K, Chapman SB, Klim A, Manson AL, Hannan TJ, Hooton TM, Kau AL, Lai HH, Dodson KW, Hultgren SJ, Earl AM. Longitudinal multi-omics analyses link gut microbiome dysbiosis with recurrent urinary tract infections in women. Nat Microbiol 2022;7:630-9. [PMID: 35505248 DOI: 10.1038/s41564-022-01107-x] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
218 Olbjørn C, Cvancarova Småstuen M, Thiis-Evensen E, Nakstad B, Vatn MH, Jahnsen J, Ricanek P, Vatn S, Moen AEF, Tannæs TM, Lindstrøm JC, Söderholm JD, Halfvarson J, Gomollón F, Casén C, Karlsson MK, Kalla R, Adams AT, Satsangi J, Perminow G. Fecal microbiota profiles in treatment-naïve pediatric inflammatory bowel disease - associations with disease phenotype, treatment, and outcome. Clin Exp Gastroenterol 2019;12:37-49. [PMID: 30774408 DOI: 10.2147/CEG.S186235] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 8.7] [Reference Citation Analysis]
219 Yao T, Chen MH, Lindemann SR. Structurally complex carbohydrates maintain diversity in gut-derived microbial consortia under high dilution pressure. FEMS Microbiol Ecol 2020;96:fiaa158. [PMID: 32815998 DOI: 10.1093/femsec/fiaa158] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
220 Cococcioni L, Panelli S, Varotto-boccazzi I, Carlo DD, Pistone D, Leccese G, Zuccotti GV, Comandatore F. IBDs and the pediatric age: Their peculiarities and the involvement of the microbiota. Digestive and Liver Disease 2021;53:17-25. [DOI: 10.1016/j.dld.2020.10.033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
221 Poletti M, Arnauts K, Ferrante M, Korcsmaros T. Organoid-based Models to Study the Role of Host-microbiota Interactions in IBD. J Crohns Colitis 2021;15:1222-35. [PMID: 33341879 DOI: 10.1093/ecco-jcc/jjaa257] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
222 Reddivari L, Veeramachaneni DNR, Walters WA, Lozupone C, Palmer J, Hewage MKK, Bhatnagar R, Amir A, Kennett MJ, Knight R, Vanamala JKP. Perinatal Bisphenol A Exposure Induces Chronic Inflammation in Rabbit Offspring via Modulation of Gut Bacteria and Their Metabolites. mSystems 2017;2:e00093-17. [PMID: 29034330 DOI: 10.1128/mSystems.00093-17] [Cited by in Crossref: 34] [Cited by in F6Publishing: 18] [Article Influence: 6.8] [Reference Citation Analysis]
223 Abboud M, Papandreou D. Gut Microbiome, Probiotics and Bone: An Updated Mini Review. Open Access Maced J Med Sci 2019;7:478-81. [PMID: 30834022 DOI: 10.3889/oamjms.2019.047] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
224 Pascale A, Marchesi N, Marelli C, Coppola A, Luzi L, Govoni S, Giustina A, Gazzaruso C. Microbiota and metabolic diseases. Endocrine. 2018;61:357-371. [PMID: 29721802 DOI: 10.1007/s12020-018-1605-5] [Cited by in Crossref: 110] [Cited by in F6Publishing: 100] [Article Influence: 27.5] [Reference Citation Analysis]
225 Vitale G, Dicitore A, Barrea L, Sbardella E, Razzore P, Campione S, Faggiano A, Colao A, Albertelli M, Altieri B, Bottiglieri F, De Cicco F, Di Molfetta S, Fanciulli G, Feola T, Ferone D, Ferraù F, Gallo M, Giannetta E, Grillo F, Grossrubatscher E, Guadagno E, Guarnotta V, Isidori AM, Lania A, Lenzi A, Calzo FL, Malandrino P, Messina E, Modica R, Muscogiuri G, Pes L, Pizza G, Pofi R, Puliani G, Rainone C, Rizza L, Rubino M, Ruggieri RM, Sesti F, Venneri MA, Zatelli MC; NIKE. From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell? Rev Endocr Metab Disord 2021;22:511-25. [PMID: 32935263 DOI: 10.1007/s11154-020-09589-y] [Reference Citation Analysis]
226 Mahnic A, Rupnik M. Different host factors are associated with patterns in bacterial and fungal gut microbiota in Slovenian healthy cohort. PLoS One 2018;13:e0209209. [PMID: 30571698 DOI: 10.1371/journal.pone.0209209] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
227 Wan P, Peng Y, Chen G, Xie M, Dai Z, Huang K, Dong W, Zeng X, Sun Y. Dicaffeoylquinic acids from Ilex kudingcha attenuate dextran sulfate sodium-induced colitis in C57BL/6 mice in association with the modulation of gut microbiota. Journal of Functional Foods 2019;61:103468. [DOI: 10.1016/j.jff.2019.103468] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
228 Lin H, Wang Q, Liu L, Chen Z, Das R, Zhao Y, Mao D, Luo Y. Colonization of Mice With Amoxicillin-Associated Klebsiella variicola Drives Inflammation via Th1 Induction and Treg Inhibition. Front Microbiol 2020;11:1256. [PMID: 32670220 DOI: 10.3389/fmicb.2020.01256] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
229 Xu M, Shen Y, Cen M, Zhu Y, Cheng F, Tang L, Zheng X, Kim JJ, Dai N, Hu W. Modulation of the Gut Microbiota-farnesoid X Receptor Axis Improves Deoxycholic Acid-induced Intestinal Inflammation in Mice. J Crohns Colitis 2021;15:1197-210. [PMID: 33417675 DOI: 10.1093/ecco-jcc/jjab003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
230 Zhou H, Zeng X, Sun D, Chen Z, Chen W, Fan L, Limpanont Y, Dekumyoy P, Maleewong W, Lv Z. Monosexual Cercariae of Schistosoma japonicum Infection Protects Against DSS-Induced Colitis by Shifting the Th1/Th2 Balance and Modulating the Gut Microbiota. Front Microbiol 2020;11:606605. [PMID: 33469451 DOI: 10.3389/fmicb.2020.606605] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
231 Bosi A, Banfi D, Bistoletti M, Giaroni C, Baj A. Tryptophan Metabolites Along the Microbiota-Gut-Brain Axis: An Interkingdom Communication System Influencing the Gut in Health and Disease. Int J Tryptophan Res 2020;13:1178646920928984. [PMID: 32577079 DOI: 10.1177/1178646920928984] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
232 Connors J, Dunn KA, Allott J, Bandsma R, Rashid M, Otley AR, Bielawski JP, Van Limbergen J. The relationship between fecal bile acids and microbiome community structure in pediatric Crohn's disease. ISME J 2020;14:702-13. [PMID: 31796936 DOI: 10.1038/s41396-019-0560-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
233 Enaud R, Hooks KB, Barre A, Barnetche T, Hubert C, Massot M, Bazin T, Clouzeau H, Bui S, Fayon M, Berger P, Lehours P, Bébéar C, Nikolski M, Lamireau T, Delhaes L, Schaeverbeke T. Intestinal Inflammation in Children with Cystic Fibrosis Is Associated with Crohn's-Like Microbiota Disturbances. J Clin Med 2019;8:E645. [PMID: 31083321 DOI: 10.3390/jcm8050645] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
234 Li P, Xiao N, Zeng L, Xiao J, Huang J, Xu Y, Chen Y, Ren Y, Du B. Structural characteristics of a mannoglucan isolated from Chinese yam and its treatment effects against gut microbiota dysbiosis and DSS-induced colitis in mice. Carbohydr Polym 2020;250:116958. [PMID: 33049862 DOI: 10.1016/j.carbpol.2020.116958] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
235 Antunes JC, Seabra CL, Domingues JM, Teixeira MO, Nunes C, Costa-Lima SA, Homem NC, Reis S, Amorim MTP, Felgueiras HP. Drug Targeting of Inflammatory Bowel Diseases by Biomolecules. Nanomaterials (Basel) 2021;11:2035. [PMID: 34443866 DOI: 10.3390/nano11082035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
236 Vancamelbeke M, Laeremans T, Vanhove W, Arnauts K, Ramalho AS, Farré R, Cleynen I, Ferrante M, Vermeire S. Butyrate Does Not Protect Against Inflammation-induced Loss of Epithelial Barrier Function and Cytokine Production in Primary Cell Monolayers From Patients With Ulcerative Colitis. J Crohns Colitis 2019;13:1351-61. [PMID: 30919886 DOI: 10.1093/ecco-jcc/jjz064] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 13.5] [Reference Citation Analysis]
237 Kang K, Sun Y, Pan D, Chang B, Sang LX. Nicotinamide Ameliorates Dextran Sulfate Sodium-Induced Chronic Colitis in Mice through Its Anti-Inflammatory Properties and Modulates the Gut Microbiota. J Immunol Res 2021;2021:5084713. [PMID: 33748287 DOI: 10.1155/2021/5084713] [Reference Citation Analysis]
238 García-Durán C, Martínez-López R, Zapico I, Pérez E, Romeu E, Arroyo J, Hernáez ML, Pitarch A, Monteoliva L, Gil C. Distinct Human Gut Microbial Taxonomic Signatures Uncovered With Different Sample Processing and Microbial Cell Disruption Methods for Metaproteomic Analysis. Front Microbiol 2021;12:618566. [PMID: 34290676 DOI: 10.3389/fmicb.2021.618566] [Reference Citation Analysis]
239 Yang ZH, Liu F, Zhu XR, Suo FY, Jia ZJ, Yao SK. Altered profiles of fecal bile acids correlate with gut microbiota and inflammatory responses in patients with ulcerative colitis. World J Gastroenterol 2021; 27(24): 3609-3629 [PMID: 34239273 DOI: 10.3748/wjg.v27.i24.3609] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
240 Liu X, Qiu B, Liu W, Zhang Y, Wang X, Li X, Li L, Zhang D. The Preventive Effects of Fermented and Germinated Foxtail Millet Whole Grain on Kidney Damage in a Diabetic Mouse Model. Front Nutr 2022;9:940404. [DOI: 10.3389/fnut.2022.940404] [Reference Citation Analysis]
241 Jang YJ, Kim WK, Han DH, Lee K, Ko G. Lactobacillus fermentum species ameliorate dextran sulfate sodium-induced colitis by regulating the immune response and altering gut microbiota. Gut Microbes 2019;10:696-711. [PMID: 30939976 DOI: 10.1080/19490976.2019.1589281] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 13.7] [Reference Citation Analysis]
242 Zhang L, Zhan H, Xu W, Yan S, Ng SC. The role of gut mycobiome in health and diseases. Therap Adv Gastroenterol 2021;14:17562848211047130. [PMID: 34589139 DOI: 10.1177/17562848211047130] [Reference Citation Analysis]
243 Nardone OM, de Sire R, Petito V, Testa A, Villani G, Scaldaferri F, Castiglione F. Inflammatory Bowel Diseases and Sarcopenia: The Role of Inflammation and Gut Microbiota in the Development of Muscle Failure. Front Immunol 2021;12:694217. [PMID: 34326845 DOI: 10.3389/fimmu.2021.694217] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
244 Montero D, Rimoldi S, Torrecillas S, Rapp J, Moroni F, Herrera A, Gómez M, Fernández-Montero Á, Terova G. Impact of polypropylene microplastics and chemical pollutants on European sea bass (Dicentrarchus labrax) gut microbiota and health. Sci Total Environ 2022;805:150402. [PMID: 34818804 DOI: 10.1016/j.scitotenv.2021.150402] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
245 Peter I, Maldonado-Contreras A, Eisele C, Frisard C, Simpson S, Nair N, Rendon A, Hawkins K, Cawley C, Debebe A, Tarassishin L, White S, Dubinsky M, Stone J, Clemente JC, Sabino J, Torres J, Hu J, Colombel JF, Olendzki B. A dietary intervention to improve the microbiome composition of pregnant women with Crohn's disease and their offspring: The MELODY (Modulating Early Life Microbiome through Dietary Intervention in Pregnancy) trial design. Contemp Clin Trials Commun 2020;18:100573. [PMID: 32617430 DOI: 10.1016/j.conctc.2020.100573] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
246 Magalhães HIR, Castelucci P. Enteric nervous system and inflammatory bowel diseases: Correlated impacts and therapeutic approaches through the P2X7 receptor. World J Gastroenterol 2021; 27(46): 7909-7924 [DOI: 10.3748/wjg.v27.i46.7909] [Reference Citation Analysis]
247 El Abbas S, Radermecker C, Bai Q, Beguin C, Schyns J, Meunier M, Pirottin D, Desmet CJ, Meuwis MA, Art T, Louis E, Tam SY, Tsai M, Bureau F, Galli SJ, Marichal T. Epithelial RABGEF1 deficiency promotes intestinal inflammation by dysregulating intrinsic MYD88-dependent innate signaling. Mucosal Immunol 2020;13:96-109. [PMID: 31628426 DOI: 10.1038/s41385-019-0211-z] [Reference Citation Analysis]
248 Tan P, Li X, Shen J, Feng Q. Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease: An Update. Front Pharmacol. 2020;11:574533. [PMID: 33041818 DOI: 10.3389/fphar.2020.574533] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
249 Ruigrok RAAA, Collij V, Sureda P, Klaassen MAY, Bolte LA, Jansen BH, Voskuil MD, Fu J, Wijmenga C, Zhernakova A, Weersma RK, Vich Vila A. The Composition and Metabolic Potential of the Human Small Intestinal Microbiota Within the Context of Inflammatory Bowel Disease. J Crohns Colitis 2021;15:1326-38. [PMID: 33515008 DOI: 10.1093/ecco-jcc/jjab020] [Reference Citation Analysis]
250 Candelli M, Franza L, Pignataro G, Ojetti V, Covino M, Piccioni A, Gasbarrini A, Franceschi F. Interaction between Lipopolysaccharide and Gut Microbiota in Inflammatory Bowel Diseases. Int J Mol Sci 2021;22:6242. [PMID: 34200555 DOI: 10.3390/ijms22126242] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
251 Ventin-Holmberg R, Eberl A, Saqib S, Korpela K, Virtanen S, Sipponen T, Salonen A, Saavalainen P, Nissilä E. Bacterial and Fungal Profiles as Markers of Infliximab Drug Response in Inflammatory Bowel Disease. J Crohns Colitis 2021;15:1019-31. [PMID: 33300552 DOI: 10.1093/ecco-jcc/jjaa252] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
252 Aschard H, Laville V, Tchetgen ET, Knights D, Imhann F, Seksik P, Zaitlen N, Silverberg MS, Cosnes J, Weersma RK, Xavier R, Beaugerie L, Skurnik D, Sokol H. Genetic effects on the commensal microbiota in inflammatory bowel disease patients. PLoS Genet. 2019;15:e1008018. [PMID: 30849075 DOI: 10.1371/journal.pgen.1008018] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
253 Liu W, Feng H, Zheng S, Xu S, Massey IY, Zhang C, Wang X, Yang F. Pb Toxicity on Gut Physiology and Microbiota. Front Physiol 2021;12:574913. [PMID: 33746764 DOI: 10.3389/fphys.2021.574913] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
254 Allam-Ndoul B, Castonguay-Paradis S, Veilleux A. Gut Microbiota and Intestinal Trans-Epithelial Permeability. Int J Mol Sci 2020;21:E6402. [PMID: 32899147 DOI: 10.3390/ijms21176402] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
255 Wang X, Yu N, Wang Z, Qiu T, Jiang L, Zhu X, Sun Y, Xiong H. Akebia trifoliata pericarp extract ameliorates inflammation through NF-κB/MAPK signaling pathways and modifies gut microbiota. Food Funct 2020;11:4682-96. [DOI: 10.1039/c9fo02917f] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
256 Liptak R, Gromova B, Maronek M, Gardlik R. Reverse phenotype transfer via fecal microbial transplantation in inflammatory bowel disease. Med Hypotheses 2019;122:41-4. [PMID: 30593419 DOI: 10.1016/j.mehy.2018.10.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
257 Skovdahl HK, Damås JK, Granlund AVB, Østvik AE, Doseth B, Bruland T, Mollnes TE, Sandvik AK. C-C Motif Ligand 20 (CCL20) and C-C Motif Chemokine Receptor 6 (CCR6) in Human Peripheral Blood Mononuclear Cells: Dysregulated in Ulcerative Colitis and a Potential Role for CCL20 in IL-1β Release. Int J Mol Sci 2018;19:E3257. [PMID: 30347808 DOI: 10.3390/ijms19103257] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
258 Sayed IM, Suarez K, Lim E, Singh S, Pereira M, Ibeawuchi SR, Katkar G, Dunkel Y, Mittal Y, Chattopadhyay R, Guma M, Boland BS, Dulai PS, Sandborn WJ, Ghosh P, Das S. Host engulfment pathway controls inflammation in inflammatory bowel disease. FEBS J 2020;287:3967-88. [PMID: 32003126 DOI: 10.1111/febs.15236] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
259 Gong W, Yu J, Zheng T, Liu P, Zhao F, Liu J, Hong Z, Ren H, Gu G, Wang G, Wu X, Zhao Y, Ren J. CCL4-mediated targeting of spleen tyrosine kinase (Syk) inhibitor using nanoparticles alleviates inflammatory bowel disease. Clin Transl Med 2021;11:e339. [PMID: 33634985 DOI: 10.1002/ctm2.339] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
260 Shi YJ, Hu SJ, Zhao QQ, Liu XS, Liu C, Wang H. Toll-like receptor 4 (TLR4) deficiency aggravates dextran sulfate sodium (DSS)-induced intestinal injury by down-regulating IL6, CCL2 and CSF3. Ann Transl Med 2019;7:713. [PMID: 32042729 DOI: 10.21037/atm.2019.12.28] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
261 Kellermayer R. Fecal microbiota transplantation: great potential with many challenges. Transl Gastroenterol Hepatol 2019;4:40. [PMID: 31231707 DOI: 10.21037/tgh.2019.05.10] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
262 Aleman FDD, Valenzano DR. Microbiome evolution during host aging. PLoS Pathog 2019;15:e1007727. [PMID: 31344129 DOI: 10.1371/journal.ppat.1007727] [Cited by in Crossref: 55] [Cited by in F6Publishing: 44] [Article Influence: 18.3] [Reference Citation Analysis]
263 Tschurtschenthaler M, Adolph TE. The Selective Autophagy Receptor Optineurin in Crohn's Disease. Front Immunol 2018;9:766. [PMID: 29692785 DOI: 10.3389/fimmu.2018.00766] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
264 Rath E, Moschetta A, Haller D. Mitochondrial function - gatekeeper of intestinal epithelial cell homeostasis. Nat Rev Gastroenterol Hepatol. 2018;15:497-516. [PMID: 29844587 DOI: 10.1038/s41575-018-0021-x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 18.3] [Reference Citation Analysis]
265 Keshteli AH, Madsen KL, Dieleman LA. Diet in the Pathogenesis and Management of Ulcerative Colitis; A Review of Randomized Controlled Dietary Interventions. Nutrients 2019;11:E1498. [PMID: 31262022 DOI: 10.3390/nu11071498] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
266 Jones GR, Molloy MP. Metformin, Microbiome and Protection Against Colorectal Cancer. Dig Dis Sci 2021;66:1409-14. [PMID: 32533543 DOI: 10.1007/s10620-020-06390-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
267 Beller L, Matthijnssens J. What is (not) known about the dynamics of the human gut virome in health and disease. Current Opinion in Virology 2019;37:52-7. [DOI: 10.1016/j.coviro.2019.05.013] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
268 Chen B, Luo J, Han Y, Du H, Liu J, He W, Zhu J, Xiao J, Wang J, Cao Y, Xiao H, Song M. Dietary Tangeretin Alleviated Dextran Sulfate Sodium-Induced Colitis in Mice via Inhibiting Inflammatory Response, Restoring Intestinal Barrier Function, and Modulating Gut Microbiota. J Agric Food Chem 2021;69:7663-74. [PMID: 34182753 DOI: 10.1021/acs.jafc.1c03046] [Reference Citation Analysis]
269 Braun T, Di Segni A, Benshoshan M, Neuman S, Levhar N, Bubis M, Picard O, Sosnovski K, Efroni G, Farage Barhom S, Glick Saar E, Lahad A, Weiss B, Yablecovitch D, Lahat A, Eliakim R, Kopylov U, Ben-horin S, Haberman Y. Individualized Dynamics in the Gut Microbiota Precede Crohn's Disease Flares. Am J Gastroenterol 2019;114:1142-51. [DOI: 10.14309/ajg.0000000000000136] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
270 Zhou X, Zhang D, Qi W, Hong T, Xiong T, Wu T, Geng F, Xie M, Nie S. Exopolysaccharides from Lactobacillus plantarum NCU116 Facilitate Intestinal Homeostasis by Modulating Intestinal Epithelial Regeneration and Microbiota. J Agric Food Chem 2021;69:7863-73. [PMID: 34236844 DOI: 10.1021/acs.jafc.1c01898] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
271 Wang T, Yu R, Zhu L, Wang X, Yang B. Differences in the Intestinal Flora of Patients with Inflammatory Bowel Disease in Southwest China. Indian J Microbiol. [DOI: 10.1007/s12088-022-01014-z] [Reference Citation Analysis]
272 Brehin C, Dubois D, Dicky O, Breinig S, Oswald E, Serino M. Evolution of Gut Microbiome and Metabolome in Suspected Necrotizing Enterocolitis: A Case-Control Study. J Clin Med 2020;9:E2278. [PMID: 32709038 DOI: 10.3390/jcm9072278] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
273 Feng W, Liu J, Ao H, Yue S, Peng C. Targeting gut microbiota for precision medicine: Focusing on the efficacy and toxicity of drugs. Theranostics 2020;10:11278-301. [PMID: 33042283 DOI: 10.7150/thno.47289] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 11.5] [Reference Citation Analysis]
274 Zhuang X, Li T, Li M, Huang S, Qiu Y, Feng R, Zhang S, Chen M, Xiong L, Zeng Z. Systematic Review and Meta-analysis: Short-Chain Fatty Acid Characterization in Patients With Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2019;25:1751-63. [DOI: 10.1093/ibd/izz188] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
275 Piccioni A, Franza L, Brigida M, Zanza C, Torelli E, Petrucci M, Nicolò R, Covino M, Candelli M, Saviano A, Ojetti V, Franceschi F. Gut Microbiota and Acute Diverticulitis: Role of Probiotics in Management of This Delicate Pathophysiological Balance. J Pers Med 2021;11:298. [PMID: 33919818 DOI: 10.3390/jpm11040298] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
276 Ballard JWO, Towarnicki SG. Mitochondria, the gut microbiome and ROS. Cell Signal 2020;75:109737. [PMID: 32810578 DOI: 10.1016/j.cellsig.2020.109737] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
277 Ding K, Hua F, Ding W. Gut Microbiome and Osteoporosis. Aging Dis 2020;11:438-47. [PMID: 32257552 DOI: 10.14336/AD.2019.0523] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
278 Qian K, Chen S, Wang J, Sheng K, Wang Y, Zhang M. A β-N-acetylhexosaminidase Amuc_2109 from Akkermansia muciniphila protects against dextran sulfate sodium-induced colitis in mice by enhancing intestinal barrier and modulating gut microbiota. Food Funct 2022;13:2216-27. [PMID: 35133390 DOI: 10.1039/d1fo04094d] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
279 Camilleri M, Lyle BJ, Madsen KL, Sonnenburg J, Verbeke K, Wu GD. Role for diet in normal gut barrier function: developing guidance within the framework of food-labeling regulations. Am J Physiol Gastrointest Liver Physiol 2019;317:G17-39. [PMID: 31125257 DOI: 10.1152/ajpgi.00063.2019] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 10.7] [Reference Citation Analysis]
280 Sun S, Xu X, Liang L, Wang X, Bai X, Zhu L, He Q, Liang H, Xin X, Wang L, Lou C, Cao X, Chen X, Li B, Wang B, Zhao J. Lactic Acid-Producing Probiotic Saccharomyces cerevisiae Attenuates Ulcerative Colitis via Suppressing Macrophage Pyroptosis and Modulating Gut Microbiota. Front Immunol 2021;12:777665. [PMID: 34899735 DOI: 10.3389/fimmu.2021.777665] [Reference Citation Analysis]
281 Figliuolo da Paz VR, Jamwal DR, Kiela PR. Intestinal Regulatory T Cells. Adv Exp Med Biol 2021;1278:141-90. [PMID: 33523448 DOI: 10.1007/978-981-15-6407-9_9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
282 Lamas B, Martins Breyner N, Houdeau E. Impacts of foodborne inorganic nanoparticles on the gut microbiota-immune axis: potential consequences for host health. Part Fibre Toxicol 2020;17:19. [PMID: 32487227 DOI: 10.1186/s12989-020-00349-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 15.5] [Reference Citation Analysis]
283 Fan L, Qi Y, Qu S, Chen X, Li A, Hendi M, Xu C, Wang L, Hou T, Si J, Chen S. B. adolescentis ameliorates chronic colitis by regulating Treg/Th2 response and gut microbiota remodeling. Gut Microbes 2021;13:1-17. [PMID: 33557671 DOI: 10.1080/19490976.2020.1826746] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
284 Tong J, Satyanarayanan SK, Su H. Nutraceuticals and probiotics in the management of psychiatric and neurological disorders: A focus on microbiota-gut-brain-immune axis. Brain Behav Immun 2020;90:403-19. [PMID: 32889082 DOI: 10.1016/j.bbi.2020.08.027] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
285 Li H, Li H. Introduction to Special Issue on Statistics in Microbiome and Metagenomics. Stat Biosci 2021;13:197-9. [DOI: 10.1007/s12561-021-09307-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
286 Wang Q, Wang C, Abdullah, Tian W, Qiu Z, Song M, Cao Y, Xiao J. Hydroxytyrosol Alleviates Dextran Sulfate Sodium-Induced Colitis by Modulating Inflammatory Responses, Intestinal Barrier, and Microbiome. J Agric Food Chem 2022. [PMID: 35133830 DOI: 10.1021/acs.jafc.1c07568] [Reference Citation Analysis]
287 Zhou X, Li W, Wang S, Zhang P, Wang Q, Xiao J, Zhang C, Zheng X, Xu X, Xue S, Hui L, Ji H, Wei B, Wang H. YAP Aggravates Inflammatory Bowel Disease by Regulating M1/M2 Macrophage Polarization and Gut Microbial Homeostasis. Cell Rep 2019;27:1176-1189.e5. [PMID: 31018132 DOI: 10.1016/j.celrep.2019.03.028] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 29.5] [Reference Citation Analysis]
288 Minot SS, Willis AD. Clustering co-abundant genes identifies components of the gut microbiome that are reproducibly associated with colorectal cancer and inflammatory bowel disease. Microbiome 2019;7:110. [PMID: 31370880 DOI: 10.1186/s40168-019-0722-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
289 Baj A, Moro E, Bistoletti M, Orlandi V, Crema F, Giaroni C. Glutamatergic Signaling Along The Microbiota-Gut-Brain Axis. Int J Mol Sci 2019;20:E1482. [PMID: 30934533 DOI: 10.3390/ijms20061482] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 17.7] [Reference Citation Analysis]
290 Di Ruscio M, Vernia F, Ciccone A, Frieri G, Latella G. Surrogate fecal biomarkers in inflammatory bowel disease: rivals or complementary tools of fecal calprotectin? Inflamm Bowel Dis. 2017;24:78-92. [PMID: 29272479 DOI: 10.1093/ibd/izx011] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
291 Huang X, Chen L, Li Z, Zheng B, Liu N, Fang Q, Jiang J, Rao T, Ouyang D. The efficacy and toxicity of antineoplastic antimetabolites: Role of gut microbiota. Toxicology 2021;460:152858. [PMID: 34273448 DOI: 10.1016/j.tox.2021.152858] [Reference Citation Analysis]
292 Montalban-Arques A, Scharl M. Intestinal microbiota and colorectal carcinoma: Implications for pathogenesis, diagnosis, and therapy. EBioMedicine 2019;48:648-55. [PMID: 31631043 DOI: 10.1016/j.ebiom.2019.09.050] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
293 Buret AG, Motta JP, Allain T, Ferraz J, Wallace JL. Pathobiont release from dysbiotic gut microbiota biofilms in intestinal inflammatory diseases: a role for iron? J Biomed Sci 2019;26:1. [PMID: 30602371 DOI: 10.1186/s12929-018-0495-4] [Cited by in Crossref: 54] [Cited by in F6Publishing: 40] [Article Influence: 18.0] [Reference Citation Analysis]
294 Guzzo GL, Andrews JM, Weyrich LS. The Neglected Gut Microbiome: Fungi, Protozoa, and Bacteriophages in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2022. [DOI: 10.1093/ibd/izab343] [Reference Citation Analysis]
295 Li S, Zhuge A, Wang K, Lv L, Bian X, Yang L, Xia J, Jiang X, Wu W, Wang S, Wang Q, Li L. Ketogenic diet aggravates colitis, impairs intestinal barrier and alters gut microbiota and metabolism in DSS-induced mice. Food Funct 2021;12:10210-25. [PMID: 34542110 DOI: 10.1039/d1fo02288a] [Reference Citation Analysis]
296 Bhatt AP, Gunasekara DB, Speer J, Reed MI, Peña AN, Midkiff BR, Magness ST, Bultman SJ, Allbritton NL, Redinbo MR. Nonsteroidal Anti-Inflammatory Drug-Induced Leaky Gut Modeled Using Polarized Monolayers of Primary Human Intestinal Epithelial Cells. ACS Infect Dis 2018;4:46-52. [PMID: 29094594 DOI: 10.1021/acsinfecdis.7b00139] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
297 Roswall J, Olsson LM, Kovatcheva-Datchary P, Nilsson S, Tremaroli V, Simon MC, Kiilerich P, Akrami R, Krämer M, Uhlén M, Gummesson A, Kristiansen K, Dahlgren J, Bäckhed F. Developmental trajectory of the healthy human gut microbiota during the first 5 years of life. Cell Host Microbe 2021;29:765-776.e3. [PMID: 33794185 DOI: 10.1016/j.chom.2021.02.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
298 Song L, Chang R, Sun X, Lu L, Gao H, Lu H, Lin R, Xu X, Liu Z, Zhan L. Macrophage-derived EDA-A2 inhibits intestinal stem cells by targeting miR-494/EDA2R/β-catenin signaling in mice. Commun Biol 2021;4:213. [PMID: 33594251 DOI: 10.1038/s42003-021-01730-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
299 Connors J, Dawe N, Van Limbergen J. The Role of Succinate in the Regulation of Intestinal Inflammation. Nutrients 2018;11:E25. [PMID: 30583500 DOI: 10.3390/nu11010025] [Cited by in Crossref: 59] [Cited by in F6Publishing: 49] [Article Influence: 14.8] [Reference Citation Analysis]
300 Wang F, Song M, Lu X, Zhu X, Deng J. Gut microbes in gastrointestinal cancers. Semin Cancer Biol 2021:S1044-579X(21)00098-5. [PMID: 33812983 DOI: 10.1016/j.semcancer.2021.03.037] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
301 Chan BD, Wong WY, Lee MM, Leung TW, Shum TY, Cho WC, Chen S, Tai WC. Centipeda minima Extract Attenuates Dextran Sodium Sulfate-Induced Acute Colitis in Mice by Inhibiting Macrophage Activation and Monocyte Chemotaxis. Front Pharmacol 2021;12:738139. [PMID: 34616300 DOI: 10.3389/fphar.2021.738139] [Reference Citation Analysis]
302 Wang R, Tang R, Li B, Ma X, Schnabl B, Tilg H. Gut microbiome, liver immunology, and liver diseases.Cell Mol Immunol. 2021;18:4-17. [PMID: 33318628 DOI: 10.1038/s41423-020-00592-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
303 Berbisá MÁF, Nielsen KR, Ingham AC, Midjord J, Hammer T, Patursson P, Vest NMO, Gregersen NO, Burisch J, Vang A. Similar Gut Bacterial Composition Between Patients With Ulcerative Colitis and Healthy Controls in a High Incidence Population: A Cross-sectional Study of the Faroe Islands IBD Cohort. Inflamm Bowel Dis 2022:izab355. [PMID: 35138361 DOI: 10.1093/ibd/izab355] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
304 Sila S, Jelić M, Trivić I, Tambić Andrašević A, Hojsak I, Kolaček S. Altered Gut Microbiota Is Present in Newly Diagnosed Pediatric Patients With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2020;70:497-502. [PMID: 31899727 DOI: 10.1097/MPG.0000000000002611] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
305 Delli Bovi AP, Marciano F, Mandato C, Siano MA, Savoia M, Vajro P. Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review. Front Med (Lausanne) 2021;8:595371. [PMID: 33718398 DOI: 10.3389/fmed.2021.595371] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
306 Chen YY, Mao LZ, Liu HH, Sun SX. Mechanism of gut butyric acid producing bacteria for prevention and treatment of inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2019; 27(14): 907-912 [DOI: 10.11569/wcjd.v27.i14.907] [Reference Citation Analysis]
307 Arroyo LG, Rossi L, Santos BP, Gomez DE, Surette MG, Costa MC. Luminal and Mucosal Microbiota of the Cecum and Large Colon of Healthy and Diarrheic Horses. Animals (Basel) 2020;10:E1403. [PMID: 32806591 DOI: 10.3390/ani10081403] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
308 Wu Z, Liu D, Deng F. The Role of Vitamin D in Immune System and Inflammatory Bowel Disease. JIR 2022;Volume 15:3167-85. [DOI: 10.2147/jir.s363840] [Reference Citation Analysis]
309 Adamkova P, Hradicka P, Kupcova Skalnikova H, Cizkova V, Vodicka P, Farkasova Iannaccone S, Kassayova M, Gancarcikova S, Demeckova V. Dextran Sulphate Sodium Acute Colitis Rat Model: A Suitable Tool for Advancing Our Understanding of Immune and Microbial Mechanisms in the Pathogenesis of Inflammatory Bowel Disease. Veterinary Sciences 2022;9:238. [DOI: 10.3390/vetsci9050238] [Reference Citation Analysis]
310 Wang J, Chen WD, Wang YD. The Relationship Between Gut Microbiota and Inflammatory Diseases: The Role of Macrophages. Front Microbiol 2020;11:1065. [PMID: 32582063 DOI: 10.3389/fmicb.2020.01065] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
311 León IC, Quesada-Vázquez S, Sáinz N, Guruceaga E, Escoté X, Moreno-Aliaga MJ. Effects of Maresin 1 (MaR1) on Colonic Inflammation and Gut Dysbiosis in Diet-Induced Obese Mice. Microorganisms 2020;8:E1156. [PMID: 32751593 DOI: 10.3390/microorganisms8081156] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
312 Giaretta PR, Suchodolski JS, Jergens AE, Steiner JM, Lidbury JA, Cook AK, Hanifeh M, Spillmann T, Kilpinen S, Syrjä P, Rech RR. Bacterial Biogeography of the Colon in Dogs With Chronic Inflammatory Enteropathy. Vet Pathol 2020;57:258-65. [PMID: 31916499 DOI: 10.1177/0300985819891259] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
313 Flores-Villanueva P, Sobhani N, Wang X, Li Y. MR1-Restricted T Cells in Cancer Immunotherapy. Cancers (Basel) 2020;12:E2145. [PMID: 32756356 DOI: 10.3390/cancers12082145] [Reference Citation Analysis]
314 Quraishi MN, Shaheen W, Oo YH, Iqbal TH. Immunological Mechanisms Underpinning Faecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease. Clin Exp Immunol. 2019;199:24-38. [PMID: 31777058 DOI: 10.1111/cei.13397] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
315 Chen R, Pang X, Li L, Zeng Z, Chen M, Zhang S. Ubiquitin-specific proteases in inflammatory bowel disease-related signalling pathway regulation. Cell Death Dis 2022;13:139. [PMID: 35145062 DOI: 10.1038/s41419-022-04566-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
316 Sitkin SI, Vakhitov TY, Demyanova EV. Microbiome, gut dysbiosis and inflammatory bowel disease: That moment when the function is more important than taxonomy. Alʹm klin med 2018;46:396-425. [DOI: 10.18786/2072-0505-2018-46-5-396-425] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
317 Xie WR, Yang XY, Deng ZH, Zheng YM, Zhang R, Wu LH, Cai JY, Kong LP, Xia HH, He XX. Effects of washed microbiota transplantation on serum uric acid levels, symptoms and intestinal barrier function in patients with acute and recurrent gout: a pilot study. Dig Dis 2021. [PMID: 34872097 DOI: 10.1159/000521273] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
318 Zheng DW, Pan P, Chen KW, Fan JX, Li CX, Cheng H, Zhang XZ. An orally delivered microbial cocktail for the removal of nitrogenous metabolic waste in animal models of kidney failure. Nat Biomed Eng 2020;4:853-62. [PMID: 32632226 DOI: 10.1038/s41551-020-0582-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
319 Yan D, Li Y, Liu Y, Li N, Zhang X, Yan C. Antimicrobial Properties of Chitosan and Chitosan Derivatives in the Treatment of Enteric Infections. Molecules 2021;26:7136. [PMID: 34885715 DOI: 10.3390/molecules26237136] [Reference Citation Analysis]
320 Wang HG, Liu SP, Ma TH, Yan W, Zhou JF, Shi YT, Shen P, Yang XZ, Wu SN. Fecal microbiota transplantation treatment for refractory ulcerative colitis with allergy to 5-aminosalicylic acid: A case report. Medicine (Baltimore) 2018;97:e0675. [PMID: 29742710 DOI: 10.1097/MD.0000000000010675] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
321 Schoultz I, Keita ÅV. Cellular and Molecular Therapeutic Targets in Inflammatory Bowel Disease-Focusing on Intestinal Barrier Function. Cells 2019;8:E193. [PMID: 30813280 DOI: 10.3390/cells8020193] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 17.0] [Reference Citation Analysis]
322 Li P, Zhang T, Xiao Y, Tian L, Cui B, Ji G, Liu YY, Zhang F. Timing for the second fecal microbiota transplantation to maintain the long-term benefit from the first treatment for Crohn's disease. Appl Microbiol Biotechnol. 2019;103:349-360. [PMID: 30357440 DOI: 10.1007/s00253-018-9447-x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
323 Wang Y, Gao X, Zhang X, Xiao F, Hu H, Li X, Dong F, Sun M, Xiao Y, Ge T, Li D, Yu G, Liu Z, Zhang T. Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn's disease. Gut Microbes 2021;13:1-18. [PMID: 33430702 DOI: 10.1080/19490976.2020.1865708] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
324 Won SM, Park E, Jeong JJ, Ganesan R, Gupta H, Gebru YA, Sharma S, Kim DJ, Suk KT. The Gut Microbiota-Derived Immune Response in Chronic Liver Disease. Int J Mol Sci 2021;22:8309. [PMID: 34361075 DOI: 10.3390/ijms22158309] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
325 Tariq R, Hayat M, Pardi D, Khanna S. Predictors of failure after fecal microbiota transplantation for recurrent Clostridioides difficile infection: a systematic review and meta-analysis. Eur J Clin Microbiol Infect Dis 2021;40:1383-92. [PMID: 33496893 DOI: 10.1007/s10096-021-04163-z] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
326 Ahmed I, Umar S. Microbiome and Colorectal Cancer. Curr Colorectal Cancer Rep 2018;14:217-25. [PMID: 33456404 DOI: 10.1007/s11888-018-0416-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
327 Wang Y, Liu X, Xia P, Li Z, FuChen X, Shen Y, Yu P, Zhang J. The Regulatory Role of MicroRNAs on Phagocytes: A Potential Therapeutic Target for Chronic Diseases. Front Immunol 2022;13:901166. [PMID: 35634335 DOI: 10.3389/fimmu.2022.901166] [Reference Citation Analysis]
328 Gou S, Huang Y, Wan Y, Ma Y, Zhou X, Tong X, Huang J, Kang Y, Pan G, Dai F, Xiao B. Multi-bioresponsive silk fibroin-based nanoparticles with on-demand cytoplasmic drug release capacity for CD44-targeted alleviation of ulcerative colitis. Biomaterials 2019;212:39-54. [DOI: 10.1016/j.biomaterials.2019.05.012] [Cited by in Crossref: 62] [Cited by in F6Publishing: 53] [Article Influence: 20.7] [Reference Citation Analysis]
329 Turpin W, Goethel A, Bedrani L, Croitoru Mdcm K. Determinants of IBD Heritability: Genes, Bugs, and More. Inflamm Bowel Dis 2018;24:1133-48. [PMID: 29701818 DOI: 10.1093/ibd/izy085] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 15.0] [Reference Citation Analysis]
330 Elaskandrany M, Patel R, Patel M, Miller G, Saxena D, Saxena A. Fungi, host immune response, and tumorigenesis. Am J Physiol Gastrointest Liver Physiol 2021;321:G213-22. [PMID: 34231392 DOI: 10.1152/ajpgi.00025.2021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
331 Du W, Han W, Dong J. Long-term oral vancomycin for refractory inflammatory bowel diseases without Clostridium difficile infection: Lessons from primary sclerosing cholangitis. Med Hypotheses 2020;144:110211. [PMID: 33254520 DOI: 10.1016/j.mehy.2020.110211] [Reference Citation Analysis]
332 Fang X, Monk JM, Nurk S, Akseshina M, Zhu Q, Gemmell C, Gianetto-Hill C, Leung N, Szubin R, Sanders J, Beck PL, Li W, Sandborn WJ, Gray-Owen SD, Knight R, Allen-Vercoe E, Palsson BO, Smarr L. Metagenomics-Based, Strain-Level Analysis of Escherichia coli From a Time-Series of Microbiome Samples From a Crohn's Disease Patient. Front Microbiol. 2018;9:2559. [PMID: 30425690 DOI: 10.3389/fmicb.2018.02559] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
333 Duarte-Silva M, Afonso PC, de Souza PR, Peghini BC, Rodrigues-Júnior V, de Barros Cardoso CR. Reappraisal of antibodies against Saccharomyces cerevisiae (ASCA) as persistent biomarkers in quiescent Crohn's disease. Autoimmunity 2019;52:37-47. [PMID: 30884988 DOI: 10.1080/08916934.2019.1588889] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
334 Yin R, Kuo HC, Hudlikar R, Sargsyan D, Li S, Wang L, Wu R, Kong AN. Gut microbiota, dietary phytochemicals and benefits to human health. Curr Pharmacol Rep 2019;5:332-44. [PMID: 33224717 DOI: 10.1007/s40495-019-00196-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
335 Liu H, Gao P, Jia B, Lu N, Zhu B, Zhang F. IBD-Associated Atg16L1T300A Polymorphism Regulates Commensal Microbiota of the Intestine. Front Immunol 2021;12:772189. [PMID: 35154071 DOI: 10.3389/fimmu.2021.772189] [Reference Citation Analysis]
336 Kantono M, Guo B. Inflammasomes and Cancer: The Dynamic Role of the Inflammasome in Tumor Development. Front Immunol 2017;8:1132. [PMID: 28955343 DOI: 10.3389/fimmu.2017.01132] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 9.6] [Reference Citation Analysis]
337 Sun Y, Zuo T, Cheung CP, Gu W, Wan Y, Zhang F, Chen N, Zhan H, Yeoh YK, Niu J, Du Y, Zhang F, Wen Y, Yu J, Sung JJY, Chan PKS, Chan FKL, Wang K, Ng SC, Miao Y. Population-Level Configurations of Gut Mycobiome Across 6 Ethnicities in Urban and Rural China. Gastroenterology 2021;160:272-286.e11. [PMID: 32956679 DOI: 10.1053/j.gastro.2020.09.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
338 Federici M. Gut microbiome and microbial metabolites: a new system affecting metabolic disorders. J Endocrinol Invest 2019;42:1011-8. [PMID: 30788772 DOI: 10.1007/s40618-019-01022-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
339 Wu T, Lyu Y, Li X, Wu M, Yu K, Li S, Ji C, Zhang Q, Zhang Y, Zhao D, Yi D, Hou Y. Impact of N-Acetylcysteine on the Gut Microbiota in the Piglets Infected With Porcine Epidemic Diarrhea Virus. Front Vet Sci 2020;7:582338. [PMID: 33511162 DOI: 10.3389/fvets.2020.582338] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
340 Wan P, Peng Y, Chen G, Xie M, Dai Z, Huang K, Dong W, Zeng X, Sun Y. Modulation of gut microbiota by Ilex kudingcha improves dextran sulfate sodium-induced colitis. Food Res Int. 2019;126:108595. [PMID: 31732076 DOI: 10.1016/j.foodres.2019.108595] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
341 Sun Y, Li L, Xia Y, Li W, Wang K, Wang L, Miao Y, Ma S. The gut microbiota heterogeneity and assembly changes associated with the IBD. Sci Rep 2019;9:440. [PMID: 30679676 DOI: 10.1038/s41598-018-37143-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
342 Hashimoto-Hill S, Alenghat T. Inflammation-Associated Microbiota Composition Across Domestic Animals. Front Genet 2021;12:649599. [PMID: 34239536 DOI: 10.3389/fgene.2021.649599] [Reference Citation Analysis]
343 Wang L, Gao M, Kang G, Huang H. The Potential Role of Phytonutrients Flavonoids Influencing Gut Microbiota in the Prophylaxis and Treatment of Inflammatory Bowel Disease. Front Nutr 2021;8:798038. [PMID: 34970585 DOI: 10.3389/fnut.2021.798038] [Reference Citation Analysis]
344 Smith BJ, Piceno Y, Zydek M, Zhang B, Syriani LA, Terdiman JP, Kassam Z, Ma A, Lynch SV, Pollard KS, El-Nachef N. Strain-resolved analysis in a randomized trial of antibiotic pretreatment and maintenance dose delivery mode with fecal microbiota transplant for ulcerative colitis. Sci Rep 2022;12:5517. [PMID: 35365713 DOI: 10.1038/s41598-022-09307-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
345 Lin Q, Kuypers M, Philpott DJ, Mallevaey T. The dialogue between unconventional T cells and the microbiota. Mucosal Immunol 2020;13:867-76. [PMID: 32704035 DOI: 10.1038/s41385-020-0326-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
346 Lovisa S, Genovese G, Danese S. Role of Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease. J Crohns Colitis. 2019;13:659-668. [PMID: 30520951 DOI: 10.1093/ecco-jcc/jjy201] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
347 Bao S, Wang H, Li W, Ji L, Wang X, Shen Q, Yang S, Zhou C, Zhang W. Dynamic alterations of the mice gut virome after Coxsackievirus B3 infection. J Med Virol 2022. [PMID: 35718835 DOI: 10.1002/jmv.27946] [Reference Citation Analysis]
348 Ghosh TS, Shanahan F, O'Toole PW. The gut microbiome as a modulator of healthy ageing. Nat Rev Gastroenterol Hepatol 2022. [PMID: 35468952 DOI: 10.1038/s41575-022-00605-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
349 Xu L, Liu B, Huang L, Li Z, Cheng Y, Tian Y, Pan G, Li H, Xu Y, Wu W, Cui Z, Xie L. Probiotic Consortia and Their Metabolites Ameliorate the Symptoms of Inflammatory Bowel Diseases in a Colitis Mouse Model. Microbiol Spectr 2022;:e0065722. [PMID: 35730951 DOI: 10.1128/spectrum.00657-22] [Reference Citation Analysis]
350 Hong C, Chen S, Hsu Y, Yen G. Protective effect of fermented okara on the regulation of inflammation, the gut microbiota, and SCFA production in rats with TNBS-induced colitis. Food Research International 2022. [DOI: 10.1016/j.foodres.2022.111390] [Reference Citation Analysis]
351 Liu Z, Liao W, Zhang Z, Sun R, Luo Y, Chen Q, Li X, Lu R, Ying Y. Metformin Affects Gut Microbiota Composition and Diversity Associated with Amelioration of Dextran Sulfate Sodium-Induced Colitis in Mice. Front Pharmacol 2021;12:640347. [PMID: 34122067 DOI: 10.3389/fphar.2021.640347] [Reference Citation Analysis]
352 Ling Z, Zhu M, Liu X, Shao L, Cheng Y, Yan X, Jiang R, Wu S. Fecal Fungal Dysbiosis in Chinese Patients With Alzheimer's Disease. Front Cell Dev Biol 2020;8:631460. [PMID: 33585471 DOI: 10.3389/fcell.2020.631460] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
353 Eshraghi RS, Deth RC, Mittal R, Aranke M, Kay SS, Moshiree B, Eshraghi AA. Early Disruption of the Microbiome Leading to Decreased Antioxidant Capacity and Epigenetic Changes: Implications for the Rise in Autism. Front Cell Neurosci 2018;12:256. [PMID: 30158857 DOI: 10.3389/fncel.2018.00256] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
354 Kakiuchi T, Yamamoto K, Imamura I, Hashiguchi K, Kawakubo H, Yamaguchi D, Fujioka Y, Okuda M. Gut microbiota changes related to Helicobacter pylori eradication with vonoprazan containing triple therapy among adolescents: a prospective multicenter study. Sci Rep 2021;11:755. [PMID: 33436953 DOI: 10.1038/s41598-020-80802-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
355 Kuypers M, Despot T, Mallevaey T. Dirty mice join the immunologist's toolkit. Microbes Infect 2021;23:104817. [PMID: 33785421 DOI: 10.1016/j.micinf.2021.104817] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
356 Badran M, Mashaqi S, Gozal D. The gut microbiome as a target for adjuvant therapy in obstructive sleep apnea. Expert Opin Ther Targets 2020;24:1263-82. [PMID: 33180654 DOI: 10.1080/14728222.2020.1841749] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
357 Ser HL, Letchumanan V, Goh BH, Wong SH, Lee LH. The Use of Fecal Microbiome Transplant in Treating Human Diseases: Too Early for Poop? Front Microbiol 2021;12:519836. [PMID: 34054740 DOI: 10.3389/fmicb.2021.519836] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
358 Okafuji H, Iida N, Kitamura K, Seishima J, Wang Z, Yutani M, Yoshio T, Yamashita T, Sakai Y, Honda M, Yamashita T, Fujinaga Y, Shinkura R, Hamaguchi Y, Mizukoshi E, Kaneko S. Oral Corticosteroids Impair Mucin Production and Alter the Posttransplantation Microbiota in the Gut. Digestion. [DOI: 10.1159/000522039] [Reference Citation Analysis]
359 Caminero A, Pinto-Sanchez MI. Host immune interactions in chronic inflammatory gastrointestinal conditions. Curr Opin Gastroenterol 2020;36:479-84. [PMID: 32868507 DOI: 10.1097/MOG.0000000000000673] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
360 Mahnic A, Breskvar M, Dzeroski S, Skok P, Pintar S, Rupnik M. Distinct Types of Gut Microbiota Dysbiosis in Hospitalized Gastroenterological Patients Are Disease Non-related and Characterized With the Predominance of Either Enterobacteriaceae or Enterococcus. Front Microbiol 2020;11:120. [PMID: 32117143 DOI: 10.3389/fmicb.2020.00120] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
361 Tang X, Wang W, Hong G, Duan C, Zhu S, Tian Y, Han C, Qian W, Lin R, Hou X. Gut microbiota-mediated lysophosphatidylcholine generation promotes colitis in intestinal epithelium-specific Fut2 deficiency. J Biomed Sci 2021;28:20. [PMID: 33722220 DOI: 10.1186/s12929-021-00711-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
362 Park H, Yeo S, Kang S, Huh CS. Longitudinal Microbiome Analysis in a Dextran Sulfate Sodium-Induced Colitis Mouse Model. Microorganisms 2021;9:370. [PMID: 33673349 DOI: 10.3390/microorganisms9020370] [Reference Citation Analysis]
363 Zhang B, Li C, Wang X, Liu C, Zhou H, Mai K, He G. Administration of commensal Shewanella sp. MR-7 ameliorates lipopolysaccharide-induced intestine dysfunction in turbot (Scophthalmus maximus L.). Fish Shellfish Immunol 2020;102:460-8. [PMID: 32389740 DOI: 10.1016/j.fsi.2020.04.068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
364 Bjarnason I, Sission G, Hayee B. A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and Crohn's disease. Inflammopharmacology 2019;27:465-73. [PMID: 31054010 DOI: 10.1007/s10787-019-00595-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 9.7] [Reference Citation Analysis]
365 Elangovan A, Allegretti JR, Fischer M. Microbiota modulation-based therapy for luminal GI disorders: current applications of probiotics and fecal microbiota transplantation. Expert Opin Biol Ther 2019;19:1343-55. [PMID: 31570017 DOI: 10.1080/14712598.2019.1673725] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
366 Bistoletti M, Bosi A, Banfi D, Giaroni C, Baj A. The microbiota-gut-brain axis: Focus on the fundamental communication pathways. Prog Mol Biol Transl Sci 2020;176:43-110. [PMID: 33814115 DOI: 10.1016/bs.pmbts.2020.08.012] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
367 Cook L, Lisko DJ, Wong MQ, Garcia RV, Himmel ME, Seidman EG, Bressler B, Levings MK, Steiner TS. Analysis of Flagellin-Specific Adaptive Immunity Reveals Links to Dysbiosis in Patients With Inflammatory Bowel Disease. Cell Mol Gastroenterol Hepatol. 2020;9:485-506. [PMID: 31790809 DOI: 10.1016/j.jcmgh.2019.11.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
368 NIH Human Microbiome Portfolio Analysis Team. A review of 10 years of human microbiome research activities at the US National Institutes of Health, Fiscal Years 2007-2016. Microbiome 2019;7:31. [PMID: 30808411 DOI: 10.1186/s40168-019-0620-y] [Cited by in Crossref: 69] [Cited by in F6Publishing: 56] [Article Influence: 23.0] [Reference Citation Analysis]
369 Chen T, Shi N, Afzali A. Chemopreventive Effects of Strawberry and Black Raspberry on Colorectal Cancer in Inflammatory Bowel Disease. Nutrients 2019;11:E1261. [PMID: 31163684 DOI: 10.3390/nu11061261] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
370 Yang H, Cai R, Kong Z, Chen Y, Cheng C, Qi S, Gu B. Teasaponin Ameliorates Murine Colitis by Regulating Gut Microbiota and Suppressing the Immune System Response. Front Med (Lausanne) 2020;7:584369. [PMID: 33363184 DOI: 10.3389/fmed.2020.584369] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
371 Mishima Y, Sartor RB. Manipulating resident microbiota to enhance regulatory immune function to treat inflammatory bowel diseases. J Gastroenterol 2020;55:4-14. [PMID: 31482438 DOI: 10.1007/s00535-019-01618-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
372 Yang L, Luo H, Tan D, Zhang S, Zhong Z, Wang S, Vong CT, Wang Y. A recent update on the use of Chinese medicine in the treatment of inflammatory bowel disease. Phytomedicine 2021;92:153709. [PMID: 34560518 DOI: 10.1016/j.phymed.2021.153709] [Reference Citation Analysis]
373 Ala M. Tryptophan metabolites modulate inflammatory bowel disease and colorectal cancer by affecting immune system. Int Rev Immunol 2021;:1-20. [PMID: 34289794 DOI: 10.1080/08830185.2021.1954638] [Reference Citation Analysis]
374 Cláudio Lima de Jesus L, Alvarenga Lima F, Dias Coelho-rocha N, Fernando da Silva T, Paz J, Azevedo V, Mancha-agresti P, Martins Drumond M. Recombinant Probiotics and Microbiota Modulation as a Good Therapy for Diseases Related to the GIT. In: Claudia Salanță L, editor. The Health Benefits of Foods - Current Knowledge and Further Development. IntechOpen; 2020. [DOI: 10.5772/intechopen.88325] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
375 Barnich N, Rodrigues M, Sauvanet P, Chevarin C, Denis S, Le Goff O, Faure-Imbert D, Hanh T, Roques CF, Chassaing B, Alric M. Beneficial Effects of Natural Mineral Waters on Intestinal Inflammation and the Mucosa-Associated Microbiota. Int J Mol Sci 2021;22:4336. [PMID: 33919372 DOI: 10.3390/ijms22094336] [Reference Citation Analysis]
376 Gîlcă-Blanariu GE, Diaconescu S, Ciocoiu M, Ștefănescu G. New Insights into the Role of Trace Elements in IBD. Biomed Res Int 2018;2018:1813047. [PMID: 30258848 DOI: 10.1155/2018/1813047] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
377 Zeng X, Jia H, Zhang X, Wang X, Wang Z, Gao Z, Yuan Y, Yue T. Supplementation of kefir ameliorates azoxymethane/dextran sulfate sodium induced colorectal cancer by modulating the gut microbiota. Food Funct 2021;12:11641-55. [PMID: 34724014 DOI: 10.1039/d1fo01729b] [Reference Citation Analysis]
378 Ishikawa T, Omori T, Kikuchi K. Bacterial biomechanics-From individual behaviors to biofilm and the gut flora. APL Bioeng 2020;4:041504. [PMID: 33163845 DOI: 10.1063/5.0026953] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
379 Seishima J, Iida N, Kitamura K, Yutani M, Wang Z, Seki A, Yamashita T, Sakai Y, Honda M, Yamashita T, Kagaya T, Shirota Y, Fujinaga Y, Mizukoshi E, Kaneko S. Gut-derived Enterococcus faecium from ulcerative colitis patients promotes colitis in a genetically susceptible mouse host. Genome Biol 2019;20:252. [PMID: 31767028 DOI: 10.1186/s13059-019-1879-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
380 Kondubhatla K, Kaushal A, Daoud A, Shabbir H, Mostafa JA. Pro-Atherogenic Inflammatory Mediators in Inflammatory Bowel Disease Patients Increase the Risk of Thrombosis, Coronary Artery Disease, and Myocardial Infarction: A Scientific Dilemma. Cureus 2020;12:e10544. [PMID: 33062549 DOI: 10.7759/cureus.10544] [Reference Citation Analysis]
381 Tian M, Li D, Ma C, Feng Y, Hu X, Chen F. Barley Leaf Insoluble Dietary Fiber Alleviated Dextran Sulfate Sodium-Induced Mice Colitis by Modulating Gut Microbiota. Nutrients 2021;13:846. [PMID: 33807544 DOI: 10.3390/nu13030846] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
382 Liu S, Zhao W, Lan P, Mou X. The microbiome in inflammatory bowel diseases: from pathogenesis to therapy. Protein Cell 2021;12:331-45. [PMID: 32601832 DOI: 10.1007/s13238-020-00745-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
383 Li C, Liang Y, Qiao Y. Messengers From the Gut: Gut Microbiota-Derived Metabolites on Host Regulation. Front Microbiol 2022;13:863407. [DOI: 10.3389/fmicb.2022.863407] [Reference Citation Analysis]
384 Guo M, Liu X, Tan Y, Kang F, Zhu X, Fan X, Wang C, Wang R, Liu Y, Qin X, Jiang M, Wang X. Sucralose enhances the susceptibility to dextran sulfate sodium (DSS) induced colitis in mice with changes in gut microbiota. Food Funct 2021;12:9380-90. [PMID: 34606537 DOI: 10.1039/d1fo01351c] [Reference Citation Analysis]
385 Li N, Shi RH. lncRNACNN3-206 activates intestinal epithelial cell apoptosis and invasion by sponging miR-212, an implication for Crohn's disease. World J Gastroenterol 2020; 26(5): 478-498 [PMID: 32089625 DOI: 10.3748/wjg.v26.i5.478] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
386 Gu SL, Gong Y, Zhang J, Chen Y, Wu Z, Xu Q, Fang Y, Wang J, Tang LL. Effect of the Short-Term Use of Fluoroquinolone and β-Lactam Antibiotics on Mouse Gut Microbiota. Infect Drug Resist 2020;13:4547-58. [PMID: 33376361 DOI: 10.2147/IDR.S281274] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
387 Gao X, Xu Z, Liu G, Wu J. Polyphenols as a versatile component in tissue engineering. Acta Biomater 2021;119:57-74. [PMID: 33166714 DOI: 10.1016/j.actbio.2020.11.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 24.0] [Reference Citation Analysis]
388 Ota S, Sakuraba H, Hiraga H, Yoshida S, Satake M, Akemoto Y, Tanaka N, Watanabe R, Takato M, Murai Y, Ueno K, Niioka T, Hayakari M, Ishiguro Y, Fukuda S. Cyclosporine protects from intestinal epithelial injury by modulating butyrate uptake via upregulation of membrane monocarboxylate transporter 1 levels. Biochem Biophys Rep 2020;24:100811. [PMID: 33102812 DOI: 10.1016/j.bbrep.2020.100811] [Reference Citation Analysis]
389 Alexeev EE, Dowdell AS, Henen MA, Lanis JM, Lee JS, Cartwright IM, Schaefer REM, Ornelas A, Onyiah JC, Vögeli B, Colgan SP. Microbial-derived indoles inhibit neutrophil myeloperoxidase to diminish bystander tissue damage. FASEB J 2021;35:e21552. [PMID: 33826788 DOI: 10.1096/fj.202100027R] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
390 Watterson WJ, Tanyeri M, Watson AR, Cham CM, Shan Y, Chang EB, Eren AM, Tay S. Droplet-based high-throughput cultivation for accurate screening of antibiotic resistant gut microbes. Elife 2020;9:e56998. [PMID: 32553109 DOI: 10.7554/eLife.56998] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 6.5] [Reference Citation Analysis]
391 D'Argenio V. Human Microbiome Acquisition and Bioinformatic Challenges in Metagenomic Studies. Int J Mol Sci 2018;19:E383. [PMID: 29382070 DOI: 10.3390/ijms19020383] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
392 Yao Y, Cai X, Ye Y, Wang F, Chen F, Zheng C. The Role of Microbiota in Infant Health: From Early Life to Adulthood. Front Immunol 2021;12:708472. [PMID: 34691021 DOI: 10.3389/fimmu.2021.708472] [Reference Citation Analysis]
393 Tang W, Huang Y, Shi P, Wang Y, Zhang Y, Xue A, Tang Z, Hu W, Sun H, Zhang P, Zheng C, Shi J, Wang S, Qiu X, Lu X, Miao S, Meng Y. Effect of Exclusive Enteral Nutrition on the Disease Process, Nutrition Status, and Gastrointestinal Microbiota for Chinese Children With Crohn's Disease. JPEN J Parenter Enteral Nutr 2021;45:826-38. [PMID: 32510616 DOI: 10.1002/jpen.1938] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
394 Zhang Z, Zhang H, Chen T, Shi L, Wang D, Tang D. Regulatory role of short-chain fatty acids in inflammatory bowel disease. Cell Commun Signal 2022;20:64. [PMID: 35546404 DOI: 10.1186/s12964-022-00869-5] [Reference Citation Analysis]
395 Yu LC. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis. J Biomed Sci 2018;25:79. [PMID: 30413188 DOI: 10.1186/s12929-018-0483-8] [Cited by in Crossref: 95] [Cited by in F6Publishing: 93] [Article Influence: 23.8] [Reference Citation Analysis]
396 Gunasekera DC, Ma J, Vacharathit V, Shah P, Ramakrishnan A, Uprety P, Shen Z, Sheh A, Brayton CF, Whary MT, Fox JG, Bream JH. The development of colitis in Il10-/- mice is dependent on IL-22. Mucosal Immunol 2020;13:493-506. [PMID: 31932715 DOI: 10.1038/s41385-019-0252-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
397 Zhang P, Zheng L, Duan Y, Gao Y, Gao H, Mao D, Luo Y. Gut microbiota exaggerates triclosan-induced liver injury via gut-liver axis. J Hazard Mater 2021;421:126707. [PMID: 34315018 DOI: 10.1016/j.jhazmat.2021.126707] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
398 Tan R, Jin M, Shao Y, Yin J, Li H, Chen T, Shi D, Zhou S, Li J, Yang D. High-sugar, high-fat, and high-protein diets promote antibiotic resistance gene spreading in the mouse intestinal microbiota. Gut Microbes 2022;14:2022442. [PMID: 35030982 DOI: 10.1080/19490976.2021.2022442] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
399 Cao R, Wu X, Guo H, Pan X, Huang R, Wang G, Liu J. Naringin Exhibited Therapeutic Effects against DSS-Induced Mice Ulcerative Colitis in Intestinal Barrier-Dependent Manner. Molecules 2021;26:6604. [PMID: 34771012 DOI: 10.3390/molecules26216604] [Reference Citation Analysis]
400 Zhai R, Xue X, Zhang L, Yang X, Zhao L, Zhang C. Strain-Specific Anti-inflammatory Properties of Two Akkermansia muciniphila Strains on Chronic Colitis in Mice. Front Cell Infect Microbiol 2019;9:239. [PMID: 31334133 DOI: 10.3389/fcimb.2019.00239] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 21.3] [Reference Citation Analysis]
401 Thoo L, Noti M, Krebs P. Keep calm: the intestinal barrier at the interface of peace and war. Cell Death Dis 2019;10:849. [PMID: 31699962 DOI: 10.1038/s41419-019-2086-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
402 Lee JY, Wasinger VC, Yau YY, Chuang E, Yajnik V, Leong RW. Molecular Pathophysiology of Epithelial Barrier Dysfunction in Inflammatory Bowel Diseases. Proteomes 2018;6:E17. [PMID: 29614738 DOI: 10.3390/proteomes6020017] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
403 Santoru ML, Piras C, Murgia F, Leoni VP, Spada M, Murgia A, Liggi S, Lai MA, Usai P, Caboni P, Manzin A, Atzori L. Metabolic Alteration in Plasma and Biopsies From Patients With IBD. Inflamm Bowel Dis 2021;27:1335-45. [PMID: 33512485 DOI: 10.1093/ibd/izab012] [Reference Citation Analysis]
404 Bilski J, Mazur-Bialy A, Wojcik D, Surmiak M, Magierowski M, Sliwowski Z, Pajdo R, Kwiecien S, Danielak A, Ptak-Belowska A, Brzozowski T. Role of Obesity, Mesenteric Adipose Tissue, and Adipokines in Inflammatory Bowel Diseases.Biomolecules. 2019;9. [PMID: 31779136 DOI: 10.3390/biom9120780] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
405 Xia P, Hou T, Ma M, Li S, Jin H, Luo X, Li J, Geng F, Li B. Konjac oligosaccharides attenuate DSS-induced ulcerative colitis in mice: mechanistic insights. Food Funct 2022;13:5626-39. [PMID: 35506498 DOI: 10.1039/d1fo04004a] [Reference Citation Analysis]
406 Deng Y, Ding X, Song Q, Zhao G, Han L, Ding B, Wang X, Hao X, Li H. Alterations in mucosa-associated microbiota in the stomach of patients with gastric cancer. Cell Oncol (Dordr) 2021;44:701-14. [PMID: 33770413 DOI: 10.1007/s13402-021-00596-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
407 Mohr AE, Gumpricht E, Sears DD, Sweazea KL. Recent advances and health implications of dietary fasting regimens on the gut microbiome. Am J Physiol Gastrointest Liver Physiol 2021;320:G847-63. [PMID: 33729005 DOI: 10.1152/ajpgi.00475.2020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
408 Li Y, Xie Z, Gao T, Li L, Chen Y, Xiao D, Liu W, Zou B, Lu B, Tian X, Han B, Guo Y, Zhang S, Lin L, Wang M, Li P, Liao Q. A holistic view of gallic acid-induced attenuation in colitis based on microbiome-metabolomics analysis. Food Funct 2019;10:4046-61. [DOI: 10.1039/c9fo00213h] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 4.3] [Reference Citation Analysis]
409 Huang J, Wei S, Cheng N, Zhong Y, Yu F, Li M, Liu D, Li S, Zhao H. Chimonanthus nitens Oliv. Leaf Granule Ameliorates DSS-Induced Acute Colitis Through Treg Cell Improvement, Oxidative Stress Reduction, and Gut Microflora Modulation. Front Cell Infect Microbiol 2022;12:907813. [DOI: 10.3389/fcimb.2022.907813] [Reference Citation Analysis]
410 Fakhoury HMA, Kvietys PR, AlKattan W, Anouti FA, Elahi MA, Karras SN, Grant WB. Vitamin D and intestinal homeostasis: Barrier, microbiota, and immune modulation. J Steroid Biochem Mol Biol 2020;200:105663. [PMID: 32194242 DOI: 10.1016/j.jsbmb.2020.105663] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 12.5] [Reference Citation Analysis]
411 Ge Y, Shi Q, Yao W, Cheng Y, Ma G. The association between inflammatory bowel disease and prostate cancer risk: a meta-analysis. Prostate Cancer Prostatic Dis 2020;23:53-8. [PMID: 31591455 DOI: 10.1038/s41391-019-0177-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
412 Chen H, Li H, Liu Z. Interplay of intestinal microbiota and mucosal immunity in inflammatory bowel disease: a relationship of frenemies. Therap Adv Gastroenterol 2020;13:1756284820935188. [PMID: 32952611 DOI: 10.1177/1756284820935188] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
413 Liu C, Jiang Y, Liu G, Guo Z, Jin Q, Long D, Zhou W, Qian K, Zhao H, Liu K. PPARGC1A affects inflammatory responses in photodynamic therapy (PDT)-treated inflammatory bowel disease (IBD). Biochemical Pharmacology 2022. [DOI: 10.1016/j.bcp.2022.115119] [Reference Citation Analysis]
414 Chen XL, Deng J, Chen X, Wan SS, Wang Y, Cao Q. High incidence and morbidity of Clostridium difficile infection among hospitalized patients with inflammatory bowel disease: A prospective observational cohort study. J Dig Dis 2019;20:460-6. [DOI: 10.1111/1751-2980.12798] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
415 Tong L, Hao H, Zhang Z, Lv Y, Liang X, Liu Q, Liu T, Gong P, Zhang L, Cao F, Pastorin G, Lee CN, Chen X, Wang JW, Yi H. Milk-derived extracellular vesicles alleviate ulcerative colitis by regulating the gut immunity and reshaping the gut microbiota. Theranostics 2021;11:8570-86. [PMID: 34373759 DOI: 10.7150/thno.62046] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
416 Cheng YW, Fischer M. Fecal Microbiota Transplantation for Ulcerative Colitis. Are We Ready for Primetime? Gastroenterol Clin North Am 2020;49:739-52. [PMID: 33121693 DOI: 10.1016/j.gtc.2020.08.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
417 Bhattarai A, Kowalczyk W, Tran TN. A literature review on large intestinal hyperelastic constitutive modeling. Clin Biomech (Bristol, Avon) 2021;88:105445. [PMID: 34416632 DOI: 10.1016/j.clinbiomech.2021.105445] [Reference Citation Analysis]
418 Roodsant T, Navis M, Aknouch I, Renes IB, van Elburg RM, Pajkrt D, Wolthers KC, Schultsz C, van der Ark KCH, Sridhar A, Muncan V. A Human 2D Primary Organoid-Derived Epithelial Monolayer Model to Study Host-Pathogen Interaction in the Small Intestine. Front Cell Infect Microbiol 2020;10:272. [PMID: 32656095 DOI: 10.3389/fcimb.2020.00272] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
419 Yu B, Wang L, Chu Y. Gut microbiota shape B cell in health and disease settings. J Leukoc Biol 2021;110:271-81. [PMID: 33974295 DOI: 10.1002/JLB.1MR0321-660R] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
420 Beaurivage C, Naumovska E, Chang YX, Elstak ED, Nicolas A, Wouters H, van Moolenbroek G, Lanz HL, Trietsch SJ, Joore J, Vulto P, Janssen RAJ, Erdmann KS, Stallen J, Kurek D. Development of a Gut-On-A-Chip Model for High Throughput Disease Modeling and Drug Discovery. Int J Mol Sci 2019;20:E5661. [PMID: 31726729 DOI: 10.3390/ijms20225661] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 16.0] [Reference Citation Analysis]
421 Huang K, Dong W, Liu W, Yan Y, Wan P, Peng Y, Xu Y, Zeng X, Cao Y. 2-O-β-d-Glucopyranosyl-l-ascorbic Acid, an Ascorbic Acid Derivative Isolated from the Fruits of Lycium Barbarum L., Modulates Gut Microbiota and Palliates Colitis in Dextran Sodium Sulfate-Induced Colitis in Mice. J Agric Food Chem 2019;67:11408-19. [PMID: 31556290 DOI: 10.1021/acs.jafc.9b04411] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
422 Xu Q, Hu M, Li M, Hou J, Zhang X, Gao Y, Chachar B, Li X. Dietary Bioactive Peptide Alanyl-Glutamine Attenuates Dextran Sodium Sulfate-Induced Colitis by Modulating Gut Microbiota. Oxid Med Cell Longev 2021;2021:5543003. [PMID: 34046146 DOI: 10.1155/2021/5543003] [Reference Citation Analysis]
423 González‐sánchez P, Denicola GM. The microbiome(s) and cancer: know thy neighbor(s). J Pathol 2021;254:332-43. [DOI: 10.1002/path.5661] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
424 Simões CD, Maganinho M, Sousa AS. FODMAPs, inflammatory bowel disease and gut microbiota: updated overview on the current evidence. Eur J Nutr 2022. [PMID: 34988652 DOI: 10.1007/s00394-021-02755-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
425 Huo X, Li D, Wu F, Li S, Qiao Y, Wang C, Wang Y, Zhou C, Sun L, Luan Z, Yan Q, Wang J, Zhang Y, Zhao T, An Y, Zhang B, Tian X, Yu Z, Ma X. Cultivated human intestinal fungus Candida metapsilosis M2006B attenuates colitis by secreting acyclic sesquiterpenoids as FXR agonists. Gut 2022:gutjnl-2021-325413. [PMID: 35173042 DOI: 10.1136/gutjnl-2021-325413] [Reference Citation Analysis]
426 Read E, Curtis MA, Neves JF. The role of oral bacteria in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2021;18:731-42. [PMID: 34400822 DOI: 10.1038/s41575-021-00488-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
427 Bilen M. Strategies and advancements in human microbiome description and the importance of culturomics. Microb Pathog 2020;149:104460. [PMID: 32853680 DOI: 10.1016/j.micpath.2020.104460] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
428 Sato M, Fujii K, Takagi H, Shibuya I, Oka D, Yamaya N, Hagita H, Matsumoto M, Inagaki K. Antibacterial and Immunosuppressive Effects of OPS-2071, a Candidate Therapy for Inflammatory Bowel Disease. Dig Dis Sci 2021. [PMID: 34463880 DOI: 10.1007/s10620-021-07237-2] [Reference Citation Analysis]
429 Wu S, Liu X, Jiang R, Yan X, Ling Z. Roles and Mechanisms of Gut Microbiota in Patients With Alzheimer's Disease. Front Aging Neurosci 2021;13:650047. [PMID: 34122039 DOI: 10.3389/fnagi.2021.650047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
430 Lang S, Duan Y, Liu J, Torralba MG, Kuelbs C, Ventura-Cots M, Abraldes JG, Bosques-Padilla F, Verna EC, Brown RS Jr, Vargas V, Altamirano J, Caballería J, Shawcross D, Lucey MR, Louvet A, Mathurin P, Garcia-Tsao G, Ho SB, Tu XM, Bataller R, Stärkel P, Fouts DE, Schnabl B. Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients With Alcoholic Hepatitis. Hepatology 2020;71:522-38. [PMID: 31228214 DOI: 10.1002/hep.30832] [Cited by in Crossref: 71] [Cited by in F6Publishing: 66] [Article Influence: 35.5] [Reference Citation Analysis]
431 Galipeau HJ, Caminero A, Turpin W, Bermudez-brito M, Santiago A, Libertucci J, Constante M, Raygoza Garay JA, Rueda G, Armstrong S, Clarizio A, Smith MI, Surette MG, Bercik P, Croitoru K, Verdu EF, Beck P, Bernstein C, Croitoru K, Dieleman L, Feagan B, Griffiths A, Guttman D, Jacobson K, Kaplan G, Krause DO, Madsen K, Marshall J, Moayyedi P, Ropeleski M, Seidman E, Silverberg M, Snapper S, Stadnyk A, Steinhart H, Surette M, Turner D, Walters T, Vallance B, Aumais G, Bitton A, Cino M, Critch J, Denson L, Deslandres C, El-matary W, Herfarth H, Higgins P, Huynh H, Hyams J, Mack D, Mcgrath J, Otley A, Panancionne R. Novel Fecal Biomarkers That Precede Clinical Diagnosis of Ulcerative Colitis. Gastroenterology 2021;160:1532-45. [DOI: 10.1053/j.gastro.2020.12.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
432 Jačan A, Kashofer K, Zenz G, Fröhlich EE, Reichmann F, Hassan AM, Holzer P. Synergistic and antagonistic interactions between antibiotics and synbiotics in modifying the murine fecal microbiome. Eur J Nutr 2020;59:1831-44. [PMID: 31263983 DOI: 10.1007/s00394-019-02035-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
433 Pop OL, Vodnar DC, Diaconeasa Z, Istrati M, Bințințan A, Bințințan VV, Suharoschi R, Gabbianelli R. An Overview of Gut Microbiota and Colon Diseases with a Focus on Adenomatous Colon Polyps. Int J Mol Sci 2020;21:E7359. [PMID: 33028024 DOI: 10.3390/ijms21197359] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
434 Vidal-Lletjós S, Andriamihaja M, Blais A, Grauso M, Lepage P, Davila AM, Gaudichon C, Leclerc M, Blachier F, Lan A. Mucosal healing progression after acute colitis in mice. World J Gastroenterol 2019; 25(27): 3572-3589 [PMID: 31367158 DOI: 10.3748/wjg.v25.i27.3572] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
435 Baydi Z, Limami Y, Khalki L, Zaid N, Naya A, Mtairag EM, Oudghiri M, Zaid Y. An Update of Research Animal Models of Inflammatory Bowel Disease. ScientificWorldJournal 2021;2021:7479540. [PMID: 34938152 DOI: 10.1155/2021/7479540] [Reference Citation Analysis]
436 Li TH, Liu L, Hou YY, Shen SN, Wang TT. C-type lectin receptor-mediated immune recognition and response of the microbiota in the gut. Gastroenterol Rep (Oxf) 2019;7:312-21. [PMID: 31687150 DOI: 10.1093/gastro/goz028] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
437 Kousgaard SJ, Michaelsen TY, Nielsen HL, Kirk KF, Brandt J, Albertsen M, Thorlacius-Ussing O. Clinical results and microbiota changes after faecal microbiota transplantation for chronic pouchitis: a pilot study. Scand J Gastroenterol 2020;55:421-9. [PMID: 32285709 DOI: 10.1080/00365521.2020.1748221] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
438 de Barrios O, Sanchez-Moral L, Cortés M, Ninfali C, Profitós-Pelejà N, Martínez-Campanario MC, Siles L, Del Campo R, Fernández-Aceñero MJ, Darling DS, Castells A, Maurel J, Salas A, Dean DC, Postigo A. ZEB1 promotes inflammation and progression towards inflammation-driven carcinoma through repression of the DNA repair glycosylase MPG in epithelial cells. Gut 2019;68:2129-41. [PMID: 31366457 DOI: 10.1136/gutjnl-2018-317294] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
439 Adamkova P, Hradicka P, Gancarcikova S, Kassayova M, Ambro L, Bertkova I, Maronek M, Farkasova Iannaccone S, Demeckova V. Single Donor FMT Reverses Microbial/Immune Dysbiosis and Induces Clinical Remission in a Rat Model of Acute Colitis. Pathogens 2021;10:152. [PMID: 33540919 DOI: 10.3390/pathogens10020152] [Reference Citation Analysis]
440 Fulci V, Stronati L, Cucchiara S, Laudadio I, Carissimi C. Emerging Roles of Gut Virome in Pediatric Diseases. Int J Mol Sci 2021;22:4127. [PMID: 33923593 DOI: 10.3390/ijms22084127] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
441 Chen Y, Chen L, Xing C, Deng G, Zeng F, Xie T, Gu L, Yang H. The risk of rheumatoid arthritis among patients with inflammatory bowel disease: a systematic review and meta-analysis. BMC Gastroenterol 2020;20:192. [PMID: 32552882 DOI: 10.1186/s12876-020-01339-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
442 Sehgal K, Khanna S. Gut microbiome and Clostridioides difficile infection: a closer look at the microscopic interface. Therap Adv Gastroenterol 2021;14:1756284821994736. [PMID: 33747125 DOI: 10.1177/1756284821994736] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
443 Marsh A, Radford-Smith G, Banks M, Lord A, Chachay V. Dietary intake of patients with inflammatory bowel disease aligns poorly with traditional Mediterranean diet principles. Nutr Diet 2021. [PMID: 34806269 DOI: 10.1111/1747-0080.12715] [Reference Citation Analysis]
444 Valitutti F, Cucchiara S, Fasano A. Celiac Disease and the Microbiome. Nutrients 2019;11:E2403. [PMID: 31597349 DOI: 10.3390/nu11102403] [Cited by in Crossref: 44] [Cited by in F6Publishing: 32] [Article Influence: 14.7] [Reference Citation Analysis]
445 Ma Y, Zhang Y, Xiang J, Xiang S, Zhao Y, Xiao M, Du F, Ji H, Kaboli PJ, Wu X, Li M, Wen Q, Shen J, Yang Z, Li J, Xiao Z. Metagenome Analysis of Intestinal Bacteria in Healthy People, Patients With Inflammatory Bowel Disease and Colorectal Cancer. Front Cell Infect Microbiol 2021;11:599734. [PMID: 33738265 DOI: 10.3389/fcimb.2021.599734] [Reference Citation Analysis]
446 Li Y, Pan H, Liu J, Li T, Liu S, Shi W, Sun C, Fan M, Xue L, Wang Y, Nie C, Zhang H, Qian H, Ying H, Wang L. l -Arabinose Inhibits Colitis by Modulating Gut Microbiota in Mice. J Agric Food Chem 2019;67:13299-306. [DOI: 10.1021/acs.jafc.9b05829] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
447 Hernandez J, Rouillé E, Chocteau F, Allard M, Haurogné K, Lezin F, Hervé JM, Bach JM, Abadie J, Lieubeau B. Nonhypoalbuminemic Inflammatory Bowel Disease in Dogs as Disease Model. Inflamm Bowel Dis 2021:izab064. [PMID: 33783501 DOI: 10.1093/ibd/izab064] [Reference Citation Analysis]
448 Bai Y, Wang S, Xu W, Weng Y, Zhu S, Sheng H, Zhu J, Zhang F. Cinobufacini ameliorates experimental colitis via modulating the composition of gut microbiota. PLoS One 2019;14:e0223231. [PMID: 31568499 DOI: 10.1371/journal.pone.0223231] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
449 Pan L, Fu T, Cheng H, Mi J, Shang Q, Yu G. Polysaccharide from edible alga Gloiopeltis furcata attenuates intestinal mucosal damage by therapeutically remodeling the interactions between gut microbiota and mucin O-glycans. Carbohydr Polym 2022;278:118921. [PMID: 34973740 DOI: 10.1016/j.carbpol.2021.118921] [Reference Citation Analysis]
450 Zhuang X, Liu C, Zhan S, Tian Z, Li N, Mao R, Zeng Z, Chen M. Gut Microbiota Profile in Pediatric Patients With Inflammatory Bowel Disease: A Systematic Review. Front Pediatr 2021;9:626232. [PMID: 33604319 DOI: 10.3389/fped.2021.626232] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
451 Han S, Gao J, Zhou Q, Liu S, Wen C, Yang X. Role of intestinal flora in colorectal cancer from the metabolite perspective: a systematic review. Cancer Manag Res 2018;10:199-206. [PMID: 29440929 DOI: 10.2147/CMAR.S153482] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 5.8] [Reference Citation Analysis]
452 Stinson LF. Establishment of the early-life microbiome: a DOHaD perspective. J Dev Orig Health Dis 2020;11:201-10. [PMID: 31601287 DOI: 10.1017/S2040174419000588] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 4.7] [Reference Citation Analysis]
453 Merigo F, Brandolese A, Facchin S, Boschi F, Di Chio M, Savarino E, D'Incà R, Sturniolo GC, Sbarbati A. Immunolocalization of leptin and leptin receptor in colorectal mucosa of ulcerative colitis, Crohn's disease and control subjects with no inflammatory bowel disease. Cell Tissue Res 2021;383:1103-22. [PMID: 33159578 DOI: 10.1007/s00441-020-03297-4] [Reference Citation Analysis]
454 Chen P, Xu H, Tang H, Zhao F, Yang C, Kwok LY, Cong C, Wu Y, Zhang W, Zhou X, Zhang H. Modulation of gut mucosal microbiota as a mechanism of probiotics-based adjunctive therapy for ulcerative colitis. Microb Biotechnol 2020;13:2032-43. [PMID: 32969200 DOI: 10.1111/1751-7915.13661] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
455 Zhao L, Xiong Q, Stary CM, Mahgoub OK, Ye Y, Gu L, Xiong X, Zhu S. Bidirectional gut-brain-microbiota axis as a potential link between inflammatory bowel disease and ischemic stroke. J Neuroinflammation 2018;15:339. [PMID: 30537997 DOI: 10.1186/s12974-018-1382-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 7.5] [Reference Citation Analysis]
456 Trindade BC, Chen GY. NOD1 and NOD2 in inflammatory and infectious diseases. Immunol Rev 2020;297:139-61. [PMID: 32677123 DOI: 10.1111/imr.12902] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
457 Sun Z, Pei W, Guo Y, Wang Z, Shi R, Chen X, Zhao X, Chen C, Liu J, Tan X, Yuan W, Mao T. Gut Microbiota-Mediated NLRP12 Expression Drives the Attenuation of Dextran Sulphate Sodium-Induced Ulcerative Colitis by Qingchang Wenzhong Decoction. Evid Based Complement Alternat Med 2019;2019:9839474. [PMID: 31061672 DOI: 10.1155/2019/9839474] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
458 Rath E, Haller D. Intestinal epithelial cell metabolism at the interface of microbial dysbiosis and tissue injury. Mucosal Immunol. [DOI: 10.1038/s41385-022-00514-x] [Reference Citation Analysis]
459 Zhuang Z, Li N, Wang J, Yang R, Wang W, Liu Z, Huang T. GWAS-associated bacteria and their metabolites appear to be causally related to the development of inflammatory bowel disease. Eur J Clin Nutr. [DOI: 10.1038/s41430-022-01074-w] [Reference Citation Analysis]
460 Azimi T, Nasiri MJ, Chirani AS, Pouriran R, Dabiri H. The role of bacteria in the inflammatory bowel disease development: a narrative review. APMIS 2018;126:275-83. [DOI: 10.1111/apm.12814] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
461 Sun R, Xu C, Feng B, Gao X, Liu Z. Critical roles of bile acids in regulating intestinal mucosal immune responses. Therap Adv Gastroenterol 2021;14:17562848211018098. [PMID: 34104213 DOI: 10.1177/17562848211018098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
462 Huang X, Ai F, Ji C, Tu P, Gao Y, Wu Y, Yan F, Yu T. A Rapid Screening Method of Candidate Probiotics for Inflammatory Bowel Diseases and the Anti-inflammatory Effect of the Selected Strain Bacillus smithii XY1. Front Microbiol 2021;12:760385. [PMID: 34975786 DOI: 10.3389/fmicb.2021.760385] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
463 Hou J, Hu M, Zhang L, Gao Y, Ma L, Xu Q. Dietary Taxifolin Protects Against Dextran Sulfate Sodium-Induced Colitis via NF-κB Signaling, Enhancing Intestinal Barrier and Modulating Gut Microbiota. Front Immunol 2020;11:631809. [PMID: 33664740 DOI: 10.3389/fimmu.2020.631809] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
464 Liu Y, Yang M, Tang L, Wang F, Huang S, Liu S, Lei Y, Wang S, Xie Z, Wang W, Zhao X, Tang B, Yang S. TLR4 regulates RORγt+ regulatory T-cell responses and susceptibility to colon inflammation through interaction with Akkermansia muciniphila. Microbiome 2022;10:98. [PMID: 35761415 DOI: 10.1186/s40168-022-01296-x] [Reference Citation Analysis]
465 Van den Abbeele P, Duysburgh C, Cleenwerck I, Albers R, Marzorati M, Mercenier A. Consistent Prebiotic Effects of Carrot RG-I on the Gut Microbiota of Four Human Adult Donors in the SHIME® Model despite Baseline Individual Variability. Microorganisms 2021;9:2142. [PMID: 34683463 DOI: 10.3390/microorganisms9102142] [Reference Citation Analysis]
466 Zhao P, Xia X, Xu X, Leung KKC, Rai A, Deng Y, Yang B, Lai H, Peng X, Shi P, Zhang H, Chiu PWY, Bian L. Nanoparticle-assembled bioadhesive coacervate coating with prolonged gastrointestinal retention for inflammatory bowel disease therapy. Nat Commun 2021;12:7162. [PMID: 34887414 DOI: 10.1038/s41467-021-27463-6] [Reference Citation Analysis]
467 Lo Presti A, Zorzi F, Del Chierico F, Altomare A, Cocca S, Avola A, De Biasio F, Russo A, Cella E, Reddel S, Calabrese E, Biancone L, Monteleone G, Cicala M, Angeletti S, Ciccozzi M, Putignani L, Guarino MPL. Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease. Front Microbiol. 2019;10:1655. [PMID: 31379797 DOI: 10.3389/fmicb.2019.01655] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 17.7] [Reference Citation Analysis]
468 Larsen IS, Jensen BAH, Bonazzi E, Choi BSY, Kristensen NN, Schmidt EGW, Süenderhauf A, Morin L, Olsen PB, Hansen LBS, Schröder T, Sina C, Chassaing B, Marette A. Fungal lysozyme leverages the gut microbiota to curb DSS-induced colitis. Gut Microbes 2021;13:1988836. [PMID: 34693864 DOI: 10.1080/19490976.2021.1988836] [Reference Citation Analysis]
469 Elias-Oliveira J, Leite JA, Pereira ÍS, Guimarães JB, Manso GMDC, Silva JS, Tostes RC, Carlos D. NLR and Intestinal Dysbiosis-Associated Inflammatory Illness: Drivers or Dampers? Front Immunol 2020;11:1810. [PMID: 32903730 DOI: 10.3389/fimmu.2020.01810] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
470 Wardill HR, Choo JM, Dmochowska N, Mavrangelos C, Campaniello MA, Bowen JM, Rogers GB, Hughes PA. Acute Colitis Drives Tolerance by Persistently Altering the Epithelial Barrier and Innate and Adaptive Immunity. Inflamm Bowel Dis 2019;25:1196-207. [PMID: 30794280 DOI: 10.1093/ibd/izz011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
471 Ren Q, Sun S, Zhang X. Redox-active nanoparticles for inflammatory bowel disease. Nano Res 2021;14:2535-57. [DOI: 10.1007/s12274-021-3303-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
472 Baj A, Bistoletti M, Bosi A, Moro E, Giaroni C, Crema F. Marine Toxins and Nociception: Potential Therapeutic Use in the Treatment of Visceral Pain Associated with Gastrointestinal Disorders. Toxins (Basel) 2019;11:E449. [PMID: 31370176 DOI: 10.3390/toxins11080449] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
473 Shi G, Jiang H, Feng J, Zheng X, Zhang D, Jiang C, Zhang J. Aloe vera mitigates dextran sulfate sodium-induced rat ulcerative colitis by potentiating colon mucus barrier. J Ethnopharmacol 2021;279:114108. [PMID: 33839199 DOI: 10.1016/j.jep.2021.114108] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
474 Zuo T, Sun Y, Wan Y, Yeoh YK, Zhang F, Cheung CP, Chen N, Luo J, Wang W, Sung JJY, Chan PKS, Wang K, Chan FKL, Miao Y, Ng SC. Human-Gut-DNA Virome Variations across Geography, Ethnicity, and Urbanization. Cell Host Microbe 2020;28:741-751.e4. [PMID: 32910902 DOI: 10.1016/j.chom.2020.08.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
475 Zhu L, Xu LZ, Zhao S, Shen ZF, Shen H, Zhan LB. Protective effect of baicalin on the regulation of Treg/Th17 balance, gut microbiota and short-chain fatty acids in rats with ulcerative colitis. Appl Microbiol Biotechnol 2020;104:5449-60. [PMID: 32322944 DOI: 10.1007/s00253-020-10527-w] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
476 Boziki M, Grigoriadis N, Papaefthymiou A, Doulberis M, Polyzos SA, Gavalas E, Deretzi G, Karafoulidou E, Kesidou E, Taloumtzis C, Theotokis P, Sofou E, Katsinelos P, Vardaka E, Fludaras I, Touloumtzi M, Koukoufiki A, Simeonidou C, Liatsos C, Kountouras J. The trimebutine effect on Helicobacter pylori-related gastrointestinal tract and brain disorders: A hypothesis. Neurochem Int 2021;144:104938. [PMID: 33535070 DOI: 10.1016/j.neuint.2020.104938] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
477 Green N, Miller T, Suskind D, Lee D. A Review of Dietary Therapy for IBD and a Vision for the Future. Nutrients 2019;11:E947. [PMID: 31035465 DOI: 10.3390/nu11050947] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
478 Wu D, Kittana H, Shu J, Kachman SD, Cui J, Ramer-Tait AE, Zempleni J. Dietary Depletion of Milk Exosomes and Their MicroRNA Cargos Elicits a Depletion of miR-200a-3p and Elevated Intestinal Inflammation and Chemokine (C-X-C Motif) Ligand 9 Expression in Mdr1a-/- Mice. Curr Dev Nutr 2019;3:nzz122. [PMID: 32154493 DOI: 10.1093/cdn/nzz122] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
479 Mullish BH, Quraishi MN, Segal JP, McCune VL, Baxter M, Marsden GL, Moore DJ, Colville A, Bhala N, Iqbal TH, Settle C, Kontkowski G, Hart AL, Hawkey PM, Goldenberg SD, Williams HRT. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. Gut 2018;67:1920-41. [PMID: 30154172 DOI: 10.1136/gutjnl-2018-316818] [Cited by in Crossref: 159] [Cited by in F6Publishing: 144] [Article Influence: 39.8] [Reference Citation Analysis]
480 Zhang H, Wang D, Shihb DQ, Zhang XL. Atg16l1 in dendritic cells is required for antibacterial defense and autophagy in murine colitis. IUBMB Life 2020;72:2686-95. [PMID: 33159835 DOI: 10.1002/iub.2406] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
481 Wu N, Mah C, Koentgen S, Zhang L, Grimm MC, El-Omar E, Hold GL. Inflammatory bowel disease and the gut microbiota. Proc Nutr Soc 2021;:1-11. [PMID: 34165053 DOI: 10.1017/S002966512100197X] [Reference Citation Analysis]
482 Maeda T, Zai H, Fukui Y, Kato Y, Kumade E, Watanabe T, Furusyo N, Nakajima H, Arai K, Ishii Y, Tateda K, Urita Y. Impact of Helicobacter pylori infection on fluid duodenal microbial community structure and microbial metabolic pathways. BMC Microbiol 2022;22:27. [PMID: 35033024 DOI: 10.1186/s12866-022-02437-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
483 Shao HQ, Tan ZJ. Microbiota-targeted therapeutics in gastrointestinal diseases. Shijie Huaren Xiaohua Zazhi 2021; 29(15): 841-848 [DOI: 10.11569/wcjd.v29.i15.841] [Reference Citation Analysis]
484 Fremder M, Kim SW, Khamaysi A, Shimshilashvili L, Eini-Rider H, Park IS, Hadad U, Cheon JH, Ohana E. A transepithelial pathway delivers succinate to macrophages, thus perpetuating their pro-inflammatory metabolic state. Cell Rep 2021;36:109521. [PMID: 34380041 DOI: 10.1016/j.celrep.2021.109521] [Reference Citation Analysis]
485 He Q, Huang J, Zheng T, Lin D, Zhang H, Li J, Sun Z. Treatment with mixed probiotics induced, enhanced and diversified modulation of the gut microbiome of healthy rats. FEMS Microbiol Ecol 2021;97:fiab151. [PMID: 34792102 DOI: 10.1093/femsec/fiab151] [Reference Citation Analysis]
486 Jin QW, Wang XD. Progress in research of vedolizumab in treatment of inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2021; 29(5): 248-255 [DOI: 10.11569/wcjd.v29.i5.248] [Reference Citation Analysis]
487 Pellicano C, Leodori G, Innocenti GP, Gigante A, Rosato E. Microbiome, Autoimmune Diseases and HIV Infection: Friends or Foes? Nutrients 2019;11:E2629. [PMID: 31684052 DOI: 10.3390/nu11112629] [Reference Citation Analysis]
488 Yang X, Yang J, Ye Z, Zhang G, Nie W, Cheng H, Peng M, Zhang K, Liu J, Zhang Z, Shi J. Physiologically Inspired Mucin Coated Escherichia coli Nissle 1917 Enhances Biotherapy by Regulating the Pathological Microenvironment to Improve Intestinal Colonization. ACS Nano 2022;16:4041-58. [PMID: 35230097 DOI: 10.1021/acsnano.1c09681] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
489 Nielsen HL, Dalager-Pedersen M, Nielsen H. High risk of microscopic colitis after Campylobacter concisus infection: population-based cohort study. Gut 2020;69:1952-8. [PMID: 32111632 DOI: 10.1136/gutjnl-2019-319771] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
490 Collij V, Klaassen MAY, Weersma RK, Vila AV. Gut microbiota in inflammatory bowel diseases: moving from basic science to clinical applications. Hum Genet 2021;140:703-8. [PMID: 32857194 DOI: 10.1007/s00439-020-02218-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
491 Ahmadi Rastegar D, Dzamko N. Leucine Rich Repeat Kinase 2 and Innate Immunity. Front Neurosci 2020;14:193. [PMID: 32210756 DOI: 10.3389/fnins.2020.00193] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
492 Hayashi A, Nagao-Kitamoto H, Kitamoto S, Kim CH, Kamada N. The Butyrate-Producing Bacterium Clostridium butyricum Suppresses Clostridioides difficile Infection via Neutrophil- and Antimicrobial Cytokine-Dependent but GPR43/109a-Independent Mechanisms. J Immunol 2021;206:1576-85. [PMID: 33597149 DOI: 10.4049/jimmunol.2000353] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
493 Mullish BH, Quraishi MN, Segal JP, McCune VL, Baxter M, Marsden GL, Moore D, Colville A, Bhala N, Iqbal TH, Settle C, Kontkowski G, Hart AL, Hawkey PM, Williams HR, Goldenberg SD. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. J Hosp Infect. 2018;100 Suppl 1:S1-S31. [PMID: 30173851 DOI: 10.1016/j.jhin.2018.07.037] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 7.7] [Reference Citation Analysis]
494 Yazbeck R, Lindsay RJ, Geier MS, Butler RN, Howarth GS. Prebiotics Fructo-, Galacto-, and Mannan-Oligosaccharide Do Not Protect against 5-Fluorouracil-Induced Intestinal Mucositis in Rats. J Nutr 2019;149:2164-73. [PMID: 31504729 DOI: 10.1093/jn/nxz192] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
495 Iyer N, Corr SC. Gut Microbial Metabolite-Mediated Regulation of the Intestinal Barrier in the Pathogenesis of Inflammatory Bowel Disease. Nutrients 2021;13:4259. [PMID: 34959809 DOI: 10.3390/nu13124259] [Reference Citation Analysis]
496 Wilson BC, Vatanen T, Cutfield WS, O'Sullivan JM. The Super-Donor Phenomenon in Fecal Microbiota Transplantation. Front Cell Infect Microbiol. 2019;9:2. [PMID: 30719428 DOI: 10.3389/fcimb.2019.00002] [Cited by in Crossref: 117] [Cited by in F6Publishing: 98] [Article Influence: 39.0] [Reference Citation Analysis]
497 Cho J, Kim D, Kang H. Exercise Preconditioning Attenuates the Response to Experimental Colitis and Modifies Composition of Gut Microbiota in Wild-Type Mice. Life (Basel). 2020;10. [PMID: 32937846 DOI: 10.3390/life10090200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
498 Kellermayer R, Zilbauer M. The Gut Microbiome and the Triple Environmental Hit Concept of Inflammatory Bowel Disease Pathogenesis. J Pediatr Gastroenterol Nutr 2020;71:589-95. [PMID: 33093364 DOI: 10.1097/MPG.0000000000002908] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
499 Eltokhi A, Sommer IE. A Reciprocal Link Between Gut Microbiota, Inflammation and Depression: A Place for Probiotics? Front Neurosci 2022;16:852506. [PMID: 35546876 DOI: 10.3389/fnins.2022.852506] [Reference Citation Analysis]
500 Zhou B, Yuan Y, Zhang S, Guo C, Li X, Li G, Xiong W, Zeng Z. Intestinal Flora and Disease Mutually Shape the Regional Immune System in the Intestinal Tract. Front Immunol 2020;11:575. [PMID: 32318067 DOI: 10.3389/fimmu.2020.00575] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
501 Li CY, Yang TM, Ou RW, Wei QQ, Shang HF. Genome-wide genetic links between amyotrophic lateral sclerosis and autoimmune diseases. BMC Med 2021;19:27. [PMID: 33541344 DOI: 10.1186/s12916-021-01903-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
502 Zhu T, Xue Q, Liu Y, Xu Y, Xiong C, Lu J, Yang H, Zhang Q, Huang Y. Analysis of Intestinal Microflora and Metabolites From Mice With DSS-Induced IBD Treated With Schistosoma Soluble Egg Antigen. Front Cell Dev Biol 2021;9:777218. [PMID: 34858992 DOI: 10.3389/fcell.2021.777218] [Reference Citation Analysis]
503 Zhu R, Tang J, Xing C, Nan Q, Liang G, Luo J, Zhou J, Miao Y, Cao Y, Dai S, Lan D. The Distinguishing Bacterial Features From Active and Remission Stages of Ulcerative Colitis Revealed by Paired Fecal Metagenomes. Front Microbiol 2022;13:883495. [DOI: 10.3389/fmicb.2022.883495] [Reference Citation Analysis]
504 Liu H, Liu H, Liu C, Shang M, Wei T, Yin P. Gut Microbiome and the Role of Metabolites in the Study of Graves’ Disease. Front Mol Biosci 2022;9:841223. [DOI: 10.3389/fmolb.2022.841223] [Reference Citation Analysis]
505 Borody TJ, Clancy A. Fecal microbiota transplantation for ulcerative colitis-where to from here? Transl Gastroenterol Hepatol 2019;4:48. [PMID: 31304425 DOI: 10.21037/tgh.2019.06.04] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
506 Estevinho MM, Rocha C, Correia L, Lago P, Ministro P, Portela F, Trindade E, Afonso J, Peyrin-Biroulet L, Magro F; GEDII (Portuguese IBD Group). Features of Fecal and Colon Microbiomes Associate With Responses to Biologic Therapies for Inflammatory Bowel Diseases: A Systematic Review. Clin Gastroenterol Hepatol 2020;18:1054-69. [PMID: 31526845 DOI: 10.1016/j.cgh.2019.08.063] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
507 Moossavi S, Arrieta M, Sanati-nezhad A, Bishehsari F. Gut-on-chip for ecological and causal human gut microbiome research. Trends in Microbiology 2022. [DOI: 10.1016/j.tim.2022.01.014] [Reference Citation Analysis]
508 Herman A, Bajaka A. The role of the intestinal microbiota in eating disorders - bulimia nervosa and binge eating disorder. Psychiatry Res 2021;300:113923. [PMID: 33857846 DOI: 10.1016/j.psychres.2021.113923] [Reference Citation Analysis]
509 Antfolk M, Jensen KB. A bioengineering perspective on modelling the intestinal epithelial physiology in vitro. Nat Commun 2020;11:6244. [PMID: 33288759 DOI: 10.1038/s41467-020-20052-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
510 Wong E, Lui K, Day AS, Leach ST. Manipulating the neonatal gut microbiome: current understanding and future perspectives. Arch Dis Child Fetal Neonatal Ed 2021:fetalneonatal-2021-321922. [PMID: 34433586 DOI: 10.1136/archdischild-2021-321922] [Reference Citation Analysis]
511 Naito Y, Kashiwagi K, Takagi T, Andoh A, Inoue R. Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use. Digestion. 2018;97:195-204. [PMID: 29316555 DOI: 10.1159/000481813] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 11.0] [Reference Citation Analysis]
512 Li HL, Wei YY, Li XH, Zhang SS, Zhang RT, Li JH, Ma BW, Shao SB, Lv ZW, Ruan H, Zhou HG, Yang C. Diosmetin has therapeutic efficacy in colitis regulating gut microbiota, inflammation, and oxidative stress via the circ-Sirt1/Sirt1 axis. Acta Pharmacol Sin 2022;43:919-32. [PMID: 34262136 DOI: 10.1038/s41401-021-00726-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
513 Zha Y, Ning K. Ontology-aware neural network: a general framework for pattern mining from microbiome data. Briefings in Bioinformatics. [DOI: 10.1093/bib/bbac005] [Reference Citation Analysis]
514 Docimo G, Cangiano A, Romano RM, Pignatelli MF, Offi C, Paglionico VA, Galdiero M, Donnarumma G, Nigro V, Esposito D, Rotondi M, Candela G, Pasquali D. The Human Microbiota in Endocrinology: Implications for Pathophysiology, Treatment, and Prognosis in Thyroid Diseases. Front Endocrinol (Lausanne) 2020;11:586529. [PMID: 33343507 DOI: 10.3389/fendo.2020.586529] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
515 Ismaeil H, Abdo W, Amer S, Tahoun A, Massoud D, Zanaty E, Bin-jumah M, Mahmoud AM. Ameliorative Effect of Heat-Killed Lactobacillus plantarum L.137 and/or Aloe vera against Colitis in Mice. Processes 2020;8:225. [DOI: 10.3390/pr8020225] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
516 Wan MLY, Co VA, El-Nezami H. Dietary polyphenol impact on gut health and microbiota. Crit Rev Food Sci Nutr 2021;61:690-711. [PMID: 32208932 DOI: 10.1080/10408398.2020.1744512] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
517 Arjomand Fard N, Armstrong H, Perry T, Wine E. Appendix and Ulcerative Colitis: a Key to Explaining the Pathogenesis and Directing Novel Therapies? Inflamm Bowel Dis 2022:izac106. [PMID: 35749298 DOI: 10.1093/ibd/izac106] [Reference Citation Analysis]
518 Yadav DK, Bai XL, Liang T. Dermatological Disorders following Liver Transplantation: An Update. Can J Gastroenterol Hepatol 2019;2019:9780952. [PMID: 31058114 DOI: 10.1155/2019/9780952] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
519 Wang Y, Zhang J, Xu L, Ma J, Lu M, Ma J, Liu Z, Wang F, Tang X. Modified Gegen Qinlian Decoction Regulates Treg/Th17 Balance to Ameliorate DSS-Induced Acute Experimental Colitis in Mice by Altering the Gut Microbiota. Front Pharmacol 2021;12:756978. [PMID: 34803700 DOI: 10.3389/fphar.2021.756978] [Reference Citation Analysis]
520 Jangid A, Fukuda S, Seki M, Horiuchi T, Suzuki Y, Taylor TD, Ohno H, Prakash T. Association of colitis with gut-microbiota dysbiosis in clathrin adapter AP-1B knockout mice. PLoS One 2020;15:e0228358. [PMID: 32208434 DOI: 10.1371/journal.pone.0228358] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
521 Fujimoto K, Uematsu S. Vaccine therapy for dysbiosis-related diseases. World J Gastroenterol 2020; 26(21): 2758-2767 [PMID: 32550752 DOI: 10.3748/wjg.v26.i21.2758] [Reference Citation Analysis]
522 Kumar M, Garand M, Al Khodor S. Integrating omics for a better understanding of Inflammatory Bowel Disease: a step towards personalized medicine. J Transl Med 2019;17:419. [PMID: 31836022 DOI: 10.1186/s12967-019-02174-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
523 Li D, Feng Y, Tian M, Ji J, Hu X, Chen F. Gut microbiota-derived inosine from dietary barley leaf supplementation attenuates colitis through PPARγ signaling activation. Microbiome 2021;9:83. [PMID: 33820558 DOI: 10.1186/s40168-021-01028-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
524 Wojciech L, Tan KSW, Gascoigne NRJ. Taming the Sentinels: Microbiome-Derived Metabolites and Polarization of T Cells. Int J Mol Sci 2020;21:E7740. [PMID: 33086747 DOI: 10.3390/ijms21207740] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
525 Zhao L, Ren G, Fan R, Feng X, Liu Z, Cheng Z, Zhang T. Spectrum and prognosis of renal histopathological lesions in patients with inflammatory bowel disease: a cross-sectional study from a single center in China. Clin Exp Med 2021. [PMID: 34698949 DOI: 10.1007/s10238-021-00766-0] [Reference Citation Analysis]
526 Cakebread J, Wallace OA, Henderson H, Jauregui R, Young W, Hodgkinson A. The impacts of bovine milk, soy beverage, or almond beverage on the growing rat microbiome. PeerJ 2022;10:e13415. [DOI: 10.7717/peerj.13415] [Reference Citation Analysis]
527 Wang H, He X, Liang S, Chen X. Role of vitamin D in ulcerative colitis: an update on basic research and therapeutic applications. Expert Rev Gastroenterol Hepatol 2022;16:251-64. [PMID: 35236213 DOI: 10.1080/17474124.2022.2048817] [Reference Citation Analysis]
528 Yu Z, Zhao J, Qin Y, Wang Y, Zhang Y, Sun S. Probiotics, Prebiotics, and Synbiotics Improve Uremic, Inflammatory, and Gastrointestinal Symptoms in End-Stage Renal Disease With Dialysis: A Network Meta-Analysis of Randomized Controlled Trials. Front Nutr 2022;9:850425. [PMID: 35445065 DOI: 10.3389/fnut.2022.850425] [Reference Citation Analysis]
529 Baldelli V, Scaldaferri F, Putignani L, Del Chierico F. The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases. Microorganisms 2021;9:697. [PMID: 33801755 DOI: 10.3390/microorganisms9040697] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
530 Chen L, Wang J. Gut microbiota and inflammatory bowel disease. WIREs Mech Dis 2022;14:e1540. [PMID: 35266651 DOI: 10.1002/wsbm.1540] [Reference Citation Analysis]
531 Tu Y, Yang R, Xu X, Zhou X. The microbiota-gut-bone axis and bone health. J Leukoc Biol 2021;110:525-37. [PMID: 33884666 DOI: 10.1002/JLB.3MR0321-755R] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
532 Han X, Ding S, Jiang H, Liu G. Roles of Macrophages in the Development and Treatment of Gut Inflammation. Front Cell Dev Biol 2021;9:625423. [PMID: 33738283 DOI: 10.3389/fcell.2021.625423] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
533 Gracey E, Dumas E, Yerushalmi M, Qaiyum Z, Inman RD, Elewaut D. The ties that bind: skin, gut and spondyloarthritis. Curr Opin Rheumatol 2019;31:62-9. [PMID: 30407224 DOI: 10.1097/BOR.0000000000000569] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
534 Xu Z, Tang H, Huang F, Qiao Z, Wang X, Yang C, Deng Q. Algal Oil Rich in n-3 PUFA Alleviates DSS-Induced Colitis via Regulation of Gut Microbiota and Restoration of Intestinal Barrier. Front Microbiol 2020;11:615404. [PMID: 33391246 DOI: 10.3389/fmicb.2020.615404] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
535 Ditz B, Christenson S, Rossen J, Brightling C, Kerstjens HAM, van den Berge M, Faiz A. Sputum microbiome profiling in COPD: beyond singular pathogen detection. Thorax 2020;75:338-44. [PMID: 31996401 DOI: 10.1136/thoraxjnl-2019-214168] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
536 Xiao W, Gao D, Chen HD, Qiao Y, Ma ZS, Duan L. Diversity Scaling Analysis of Chinese Gut Microbiomes Across Ethnicities and Lifestyles. Front Microbiol 2021;12:736393. [PMID: 34956110 DOI: 10.3389/fmicb.2021.736393] [Reference Citation Analysis]
537 Oligschlaeger Y, Yadati T, Houben T, Condello Oliván CM, Shiri-Sverdlov R. Inflammatory Bowel Disease: A Stressed "Gut/Feeling". Cells 2019;8:E659. [PMID: 31262067 DOI: 10.3390/cells8070659] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
538 Woloszynek S, Zhao Z, Chen J, Rosen GL. 16S rRNA sequence embeddings: Meaningful numeric feature representations of nucleotide sequences that are convenient for downstream analyses. PLoS Comput Biol 2019;15:e1006721. [PMID: 30807567 DOI: 10.1371/journal.pcbi.1006721] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
539 Zhang Y, Peng L, Li W, Dai T, Nie L, Xie J, Ai Y, Li L, Tian Y, Sheng J. Polyphenol Extract of Moringa Oleifera Leaves Alleviates Colonic Inflammation in Dextran Sulfate Sodium-Treated Mice. Evid Based Complement Alternat Med 2020;2020:6295402. [PMID: 33299453 DOI: 10.1155/2020/6295402] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
540 Wan F, Wang M, Zhong R, Chen L, Han H, Liu L, Zhao Y, Lv H, Hou F, Yi B, Zhang H. Supplementation With Chinese Medicinal Plant Extracts From Lonicera hypoglauca and Scutellaria baicalensis Mitigates Colonic Inflammation by Regulating Oxidative Stress and Gut Microbiota in a Colitis Mouse Model. Front Cell Infect Microbiol 2021;11:798052. [PMID: 35059326 DOI: 10.3389/fcimb.2021.798052] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
541 Vuyyuru SK, Kedia S, Kalaivani M, Sahu P, Kante B, Kumar P, Ranjan MK, Makharia G, Ananthakrishnan A, Ahuja V. Efficacy and safety of fecal transplantation versus targeted therapies in ulcerative colitis: network meta-analysis. Future Microbiol 2021;16:1215-27. [PMID: 34590904 DOI: 10.2217/fmb-2020-0242] [Reference Citation Analysis]
542 Alexander T, Snowden JA, Burman J, Chang HD, Del Papa N, Farge D, Lindsay JO, Malard F, Muraro PA, Nitti R, Salas A, Sharrack B, Mohty M, Greco R. Intestinal Microbiome in Hematopoietic Stem Cell Transplantation For Autoimmune Diseases: Considerations and Perspectives on Behalf of Autoimmune Diseases Working Party (ADWP) of the EBMT. Front Oncol 2021;11:722436. [PMID: 34745944 DOI: 10.3389/fonc.2021.722436] [Reference Citation Analysis]
543 El-Houssaini HH, Elnabawy OM, Nasser HA, Elkhatib WF. Influence of subinhibitory antifungal concentrations on extracellular hydrolases and biofilm production by Candida albicans recovered from Egyptian patients. BMC Infect Dis 2019;19:54. [PMID: 30651066 DOI: 10.1186/s12879-019-3685-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
544 Chang CS, Liao YC, Huang CT, Lin CM, Cheung CHY, Ruan JW, Yu WH, Tsai YT, Lin IJ, Huang CH, Liou JS, Chou YH, Chien HJ, Chuang HL, Juan HF, Huang HC, Chan HL, Liao YC, Tang SC, Su YW, Tan TH, Bäumler AJ, Kao CY. Identification of a gut microbiota member that ameliorates DSS-induced colitis in intestinal barrier enhanced Dusp6-deficient mice. Cell Rep 2021;37:110016. [PMID: 34818535 DOI: 10.1016/j.celrep.2021.110016] [Reference Citation Analysis]
545 He X, Liu J, Long G, Xia XH, Liu M. 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-glucoside, a major bioactive component from Polygoni multiflori Radix (Heshouwu) suppresses DSS induced acute colitis in BALb/c mice by modulating gut microbiota. Biomed Pharmacother 2021;137:111420. [PMID: 33761623 DOI: 10.1016/j.biopha.2021.111420] [Reference Citation Analysis]